Earnings Release • Aug 2, 2019
Earnings Release
Open in ViewerOpens in native device viewer

rbs.com
We retain the outlook we provided in the 2018 Annual Report and Accounts. We anticipate a further £1.2 billion of FX recycling gains in H2 2019 upon the transfer of ownership of NWM N.V. to NWM Plc, subject to regulatory approval, which is capital and TNAV neutral.
Given current market conditions, continued economic and political uncertainty and the contraction of the yield curve, it is very unlikely that we will achieve our target return on tangible equity of more than 12% and cost:income ratio of less than 50% in 2020. These remain our strategic targets and we believe they are achievable in the medium term.
Notes:
(1) NatWest Markets has acted as Active Bookrunner for Issuers across Corporate, FI and SSA sectors, helping them to raise c. £140 billion in debt capital markets in H1 2019.
(2) The targets, expectations and trends discussed in this section represent management's current expectations and are subject to change, including as a result of the factors described in the "Risk Factors" section on pages 253 to 263 of the 2018 Annual Report and Accounts and pages 46 and 47 of this document. These statements constitute forward-looking statements. Refer to Forward-looking statements in this announcement.
| Half year ended | Quarter ended | |||||
|---|---|---|---|---|---|---|
| Performance key metrics and ratios (1) | 30 June 2019 |
30 June 2018 |
30 June 2019 |
31 March 2019 |
30 June 2018 |
|
| Operating profit before tax | £2,694m | £1,826m | £1,681m | £1,013m | £613m | |
| Profit attributable to ordinary shareholders | £2,038m | £888m | £1,331m | £707m | £96m | |
| Net interest margin (NIM) (1) | 1.83% | 2.02% | 1.78% | 1.89% | 2.01% | |
| Bank net interest margin (RBS NIM excluding NWM) (1) | 2.04% | 2.13% | 2.02% | 2.07% | 2.11% | |
| Average interest earning assets | £440bn | £431bn | £445bn | £436bn | £435bn | |
| Cost:income ratio (1) | 57.2% | 70.4% | 52.6% | 63.4% | 80.0% | |
| Earnings per share | ||||||
| - basic | 16.9p | 7.4p | 11.0p | 5.9p | 0.8p | |
| - basic fully diluted | 16.8p | 7.4p | 11.0p | 5.8p | 0.8p | |
| Return on tangible equity (1) | 12.1% | 5.3% | 15.8% | 8.3% | 1.1% | |
| Average tangible equity | £34bn | £34bn | £34bn | £34bn | £34bn | |
| Average number of ordinary shares | ||||||
| outstanding during the period (millions) | ||||||
| - basic | 12,058 | 11,980 | 12,069 | 12,047 | 12,003 | |
| - fully diluted (2) | 12,096 | 12,039 | 12,104 | 12,087 | 12,062 |
| 30 June | 31 March | 31 December | |
|---|---|---|---|
| Balance sheet related key metrics and ratios (1) | 2019 | 2019 | 2018 |
| Total assets | £729.9bn | £719.1bn | £694.2bn |
| Funded assets (1) | £584.3bn | £585.1bn | £560.9bn |
| Loans to customers - amortised cost | £310.6bn | £306.4bn | £305.1bn |
| Impairment provisions | £3.2bn | £3.1bn | £3.3bn |
| Loan impairment rate (1) | 30bps | 11bps | 2bps |
| Customer deposits | £361.6bn | £355.2bn | £360.9bn |
| Liquidity coverage ratio (LCR) | 154% | 153% | 158% |
| Liquidity portfolio | £203bn | £190bn | £198bn |
| Net stable funding ratio (NSFR) (3) | 140% | 137% | 141% |
| Loan:deposit ratio (1) | 86% | 86% | 85% |
| Total wholesale funding | £78bn | £77bn | £74bn |
| Short-term wholesale funding | £19bn | £19bn | £15bn |
| Common Equity Tier (CET1) ratio | 16.0% | 16.2% | 16.2% |
| Total capital ratio | 20.9% | 21.1% | 21.8% |
| Pro forma CET 1 ratio, pre dividend accrual (4) | 17.1% | 16.3% | 16.9% |
| Risk-weighted assets (RWAs) | £188.5bn | £190.8bn | £188.7bn |
| CRR leverage ratio | 5.2% | 5.2% | 5.4% |
| UK leverage ratio | 5.9% | 6.0% | 6.2% |
| Tangible net asset value (TNAV) per ordinary share | 290p | 289p | 287p |
| Tangible net asset value (TNAV) per ordinary share - fully diluted (1,2) | 289p | 288p | 286p |
| Tangible equity | £35,036m | £34,962m | £34,566m |
| Number of ordinary shares in issue (millions) (5) | 12,091 | 12,090 | 12,049 |
| Number of ordinary shares in issue (millions) - fully diluted (2,5) | 12,124 | 12,129 | 12,088 |
Notes:
(1) Refer to Appendix 2 for details of basis of preparation and reconciliation of non-IFRS financial and performance measures where relevant.
(2) Includes the effect of dilutive share options and convertible securities. Dilutive shares on an average basis for H1 2019 were 38 million shares and for Q2 2019 were 35 million shares; (Q1 2019 - 40 million shares, H1 2018 - 59 million shares; Q2 2018 - 59 million shares), and as at 30 June 2019 were 33 million shares (31 March 2019 - 39 million shares; 31 December 2018 - 39 million shares).
(3) NSFR reported in line with CRR2 regulations finalised in June 2019.
(4) The pro forma CET 1 ratio at 30 June 2019 excluded a charge of £241 million (2p per share) for the interim dividend, a special dividend of £1,449 million (12p per share) and a foreseeable final dividend related to interim profits of £363 million (3p per share). 31 March 2019 excluded a charge of £241 million (2p per share) for the Q1 2019 foreseeable dividend. 31 December 2018 excluded a charge of £422 million (3.5p per share) for the final dividend and £904 million (7.5p per share) for the special dividend paid following the Annual General Meeting held on 25 April 2019.
(5) Includes 17 million treasury shares (31 March 2019 - 24 million shares; 31 December 2018 - 8 million shares).
Effective from 1 January 2019, Business Banking has been transferred from UK Personal and Business Banking (UK PBB) to Commercial Banking as the nature of the business, including distribution channels, products and customers, are more closely aligned to the Commercial Banking business. Concurrent with the transfer, UK PBB has been renamed UK Personal Banking (UK PB) and the previous franchise combining UK PBB (now UK PB) and Ulster Bank RoI has been renamed Personal & Ulster. Comparatives have been re-stated.
This document contains a number of non-IFRS financial measures and performance metrics not defined under IFRS. For details of the basis of preparation and reconciliations where appropriate of, refer to Appendix 2 of this document.
| Half year ended Quarter ended |
|||||
|---|---|---|---|---|---|
| 30 June | 30 June | 30 June | 31 March | 30 June | |
| 2019 | 2018 | 2019 | 2019 | 2018 | |
| £m | £m | £m | £m | £m | |
| Net interest income | 4,004 | 4,326 | 1,971 | 2,033 | 2,180 |
| Own credit adjustments | (46) | 39 | (3) | (43) | 18 |
| Strategic disposals | 1,035 | - | 1,035 | - | - |
| Other non-interest income | 2,124 | 2,337 | 1,077 | 1,047 | 1,202 |
| Non-interest income | 3,113 | 2,376 | 2,109 | 1,004 | 1,220 |
| Total income | 7,117 | 6,702 | 4,080 | 3,037 | 3,400 |
| Litigation and conduct costs | (60) | (801) | (55) | (5) | (782) |
| Strategic costs | (629) | (350) | (434) | (195) | (141) |
| Other expenses | (3,411) | (3,584) | (1,673) | (1,738) | (1,801) |
| Operating expenses | (4,100) | (4,735) | (2,162) | (1,938) | (2,724) |
| Profit before impairment losses | 3,017 | 1,967 | 1,918 | 1,099 | 676 |
| Impairment losses | (323) | (141) | (237) | (86) | (63) |
| Operating profit before tax | 2,694 | 1,826 | 1,681 | 1,013 | 613 |
| Tax charge | (194) | (709) | 22 | (216) | (396) |
| Profit for the period | 2,500 | 1,117 | 1,703 | 797 | 217 |
| Attributable to: | |||||
| Ordinary shareholders | 2,038 | 888 | 1,331 | 707 | 96 |
| Other owners | 202 | 245 | 102 | 100 | 144 |
| Non-controlling interests | 260 | (16) | 270 | (10) | (23) |
| Notable items within total income | |||||
| Alawwal bank merger gain in NatWest Markets | 444 | - | 444 | - | - |
| FX recycling gain in Central items & other | 290 | - | 290 | - | - |
| Legacy liability release in Central items & other | 256 | - | 256 | - | - |
| IFRS volatility in Central items & other(1) | 17 | (111) | 21 | (4) | 17 |
| UK PB debt sale gain | 2 | 26 | - | 2 | - |
| FX gains in Central items & other | 20 | 4 | - | 20 | 19 |
| Commercial Banking fair value and disposal (loss)/gain | (17) | 192 | (15) | (2) | 115 |
| NatWest Markets legacy business disposal | (27) | (57) | (23) | (4) | (41) |
| Notable items within operating expenses | |||||
| Push payment fraud costs | (18) | - | (18) | ||
| Litigation and conduct costs | (60) | (801) | (55) | (5) | (782) |
| of which: US RMBS | 7 | (802) | 7 | - | (803) |
| of which: DoJ | - | (1,040) | - | - | (1,040) |
| Nomura | - | 241 | - | - | 241 |
Note:
(1) IFRS volatility relates to loans which are economically hedged but for which hedge accounting is not permitted under IFRS.
Total income increased by £415 million, or 6.2%, compared with H1 2018 principally due to a £444 million gain relating to the Alawwal bank merger completion, FX recycling gains of £290 million and a £256 million legacy liability release, partially offset by lower central Treasury income, reflecting increased MREL costs and lower structural hedge income. Excluding NatWest Markets, Central items and notable items, income decreased by 1.7% compared with H1 2018 reflecting continuing margin pressure.
Bank NIM of 2.04% was 9 basis points lower than H1 2018 primarily reflecting competitive pressures within the personal business, while in Commercial Banking NIM increased by 3 basis points.
Operating expenses decreased by £635 million, or 13.4%, compared with H1 2018 primarily reflecting a £741 million reduction in litigation and conduct costs, principally due to the net RMBS charge in H1 2018, partially offset by a £279 million increase in strategic costs.
Other expenses reduced by £173 million compared with H1 2018, despite an additional £18 million of authorised push payment fraud costs in line with new industry practice. The majority of the reduction in expenses is in Central items and reflects one-off releases in H1 2019 and innovation and other costs that were held centrally in H1 2018 which are now allocated to the franchises. Headcount reduced by c.3,400, or 4.9%, compared with H1 2018.
A net impairment loss of £323 million, 21 basis points of gross customer loans, increased by £182 million compared with H1 2018 primarily reflecting a small number of single name charges in Commercial Banking and lower recoveries in UK PB, resulting from debt sales in recent years.
The tax charge includes a £215 million deferred tax asset credit associated with the transfer of taxable losses from NatWest Markets Plc to RBS Plc under ring-fencing regulations.
Includes a charge of £274 million in relation to the gain recognised on completion of the Alawwal bank merger.
Our brands are our main connection with customers. Each takes a clear and differentiated position with the aim of helping us strengthen our relationship with them. For this reason we track customer advocacy for our key brands using the net-promoter score (NPS) – a commonly-used metric in banking and other industries across the world.
We know that we still have much to do. Our recent programme of branch closures has had a detrimental impact on NPS, particularly for the Royal Bank of Scotland. Scores here are recovering in Personal Banking, and we are optimistic the same will happen in Business Banking. We are determined to make a difference with the things that matter most to our customers. We are fixing our core processes to get our service right first time more consistently while at the same time innovating to deliver better solutions.
The tables below show NPS and Trust scores for our key brands.
| Q1 2018 | Q2 2018 | Q3 2018 | Q4 2018 | Q1 2019 | Q2 2019 | |
|---|---|---|---|---|---|---|
| NatWest | 12 | 13 | 12 | 11 | 11 | 11 |
| Royal Bank of Scotland | (14) | (21) | (22) | (17) | (14) | (10) |
| Ulster Bank Northern Ireland | (6) | (11) | (9) | (10) | (3) | 1 |
| Ulster Bank Republic of Ireland | (5) | (7) | (6) | (6) | (7) | (11) |
Source: Ipsos MORI FRS 6 month rolling data. Latest base sizes: 3,111 for NatWest (England & Wales); 421 for Royal Bank of Scotland (Scotland). Based on the question: "How likely is it that you would recommend (brand) to a relative, friend or colleague in the next 12 months for current account banking?" Base: Claimed main banked current account customers.
Source: Coyne Research 12 month rolling data. Question: "Please indicate to what extent you would be likely to recommend (brand) to your friends or family using a scale of 0 to 10 where 0 is not at all likely and 10 is extremely likely". Latest base sizes: 254 Northern Ireland; 292 Republic of Ireland
| Q1 2018 | Q2 2018 | Q3 2018 | Q4 2018 | Q1 2019 | Q2 2019 | |
|---|---|---|---|---|---|---|
| NatWest | (10) | (6) | (5) | (9) | (8) | (9) |
| Royal Bank of Scotland | (22) | (23) | (29) | (36) | (36) | (36) |
Source: MarketVue Business Banking from Savanta Q2 2019. Based on interviews with businesses with an annual turnover up to £2 million. Latest base sizes: 1098 for NatWest (England & Wales), 442 for Royal Bank of Scotland (Scotland). Question: "How likely would you be to recommend (bank)". Base: Claimed main bank. Data weighted by region and turnover to be representative of businesses in Great Britain.
| Q1 2018 | Q2 2018 | Q3 2018 | Q4 2018 | Q1 2019 | Q2 2019 | |
|---|---|---|---|---|---|---|
| NatWest | 23 | 22 | 21 | 21 | 20 | 20 |
| Royal Bank of Scotland | 10 | 17 | 21 | 20 | 18 | 21 |
Source: MarketVue Business Banking from Savanta Q2 2019. Based on interviews with businesses with an annual turnover over £2 million. Latest base sizes: 550 for NatWest (England & Wales), 89 for Royal Bank of Scotland (Scotland). Question: "How likely would you be to recommend (bank)". Base: Claimed main bank. Data weighted by region and turnover to be representative of businesses in Great Britain.
We also use independent experts to measure our customers' trust in the bank. Each quarter we ask customers to what extent they trust or distrust their bank to do the right thing. The score is a net measure of those customers that trust their bank (a lot or somewhat) minus those that distrust their bank (a lot or somewhat).
| Q1 2018 | Q2 2018 | Q3 2018 | Q4 2018 | Q1 2019 | Q2 2019 | |
|---|---|---|---|---|---|---|
| NatWest | 59 | 58 | 64 | 56 | 60 | 61 |
| Royal Bank of Scotland | 15 | 27 | 25 | 27 | 28 | 38 |
Source: Populus. Latest quarter's data. Measured as a net % of those that trust RBS/NatWest to do the right thing, less those that do not. Latest base sizes: 908 for NatWest (England & Wales), 188 for Royal Bank of Scotland (Scotland).
Half year ended Quarter ended 30 June 30 June 30 June 31 March 30 June 2019 2018 2019 2019 2018 £m £m £m £m £m Total income 2,447 2,551 1,202 1,245 1,253 Operating expenses (1,229) (1,291) (594) (635) (605) Impairment losses (181) (131) (69) (112) (63) Operating profit 1,037 1,129 539 498 585 Return on equity 25.6% 31.4% 26.5% 24.7% 33.0% Net interest margin 2.57% 2.71% 2.51% 2.62% 2.68% Cost:income ratio 50.2% 50.6% 49.4% 51.0% 48.3% As at 30 June 31 March 31 December 2019 2019 2018 £bn £bn £bn Net loans to customers (amortised cost) 151.9 150.6 148.9 Customer deposits 147.5 145.7 145.3 RWAs 37.0 35.8 34.3 Loan impairment rate 18bps 30bps 38bps
| Half year ended | Quarter ended | |||||
|---|---|---|---|---|---|---|
| 30 June | 30 June | 30 June | 31 March | 30 June | ||
| 2019 | 2018 | 2019 | 2019 | 2018 | ||
| €m | €m | €m | €m | €m | ||
| Total income | 324 | 355 | 158 | 166 | 190 | |
| Operating expenses | (322) | (285) | (166) | (156) | (140) | |
| Impairment releases | 24 | 30 | 11 | 13 | 39 | |
| Operating profit | 26 | 100 | 3 | 23 | 89 | |
| Return on equity | 2.1% | 7.0% | 0.6% | 3.8% | 12.5% | |
| Net interest margin | 1.63% | 1.85% | 1.62% | 1.65% | 1.91% | |
| Cost:income ratio | 99.3% | 80.8% | 105.1% | 93.8% | 74.7% | |
| As at | ||||||
| 30 June | 31 March | 31 December | ||||
| 2019 | 2019 | 2018 | ||||
| €bn | €bn | €bn | ||||
| Net loans to customers (amortised cost) | 21.2 | 21.1 | 21.0 | |||
| Customer deposits | 21.3 | 20.3 | 20.1 | |||
| RWAs | 15.8 | 16.4 | 16.4 | |||
| Loan impairment rate | (20)bps | (24)bps | (38)bps |
● Total income was €8 million, or 4.8%, lower largely due to an €11 million one-off benefit following a restructure of interest rate swaps on free funds in Q1 2019. Net interest margin was 3 basis points lower, primarily due to an increase in cash placements.
● Net loans to customers increased by €0.1 billion, or 0.5%, while customer deposits increased by €1.0 billion, or 4.9%. Q2 2019 compared with Q2 2018
Commercial Banking
| Half year ended | Quarter ended | |||||
|---|---|---|---|---|---|---|
| 30 June | 30 June | 30 June | 31 March | 30 June | ||
| 2019 | 2018 | 2019 | 2019 | 2018 | ||
| £m | £m | £m | £m | £m | ||
| Total income | 2,165 | 2,390 | 1,083 | 1,082 | 1,232 | |
| Operating expenses | (1,262) | (1,140) | (622) | (640) | (545) | |
| Impairment losses | (202) | (35) | (197) | (5) | (23) | |
| Operating profit | 701 | 1,215 | 264 | 437 | 664 | |
| Return on equity | 8.8% | 15.1% | 6.2% | 11.5% | 16.4% | |
| Net interest margin | 1.98% | 1.95% | 1.97% | 1.99% | 1.98% | |
| Cost:income ratio | 56.9% | 46.4% | 56.1% | 57.8% | 43.0% | |
| As at | ||||||
| 30 June | 31 March | 31 December | ||||
| 2019 | 2019 | 2018 | ||||
| £bn | £bn | £bn | ||||
| Net loans to customer (amortised cost) | 101.4 | 100.8 | 101.4 | |||
| Customer deposits | 133.4 | 131.8 | 134.4 | |||
| RWAs | 77.8 | 78.1 | 78.4 | |||
| Loan impairment rate | 77bps | 2bps | 2bps |
Q2 2019 compared with Q1 2019
Q2 2019 compared with Q2 2018
● Total income decreased by £149 million, or 12.1%, reflecting asset disposal and fair value losses of £15 million compared to asset disposal and fair value gains of £115 million in Q2 2018 and lower non-interest income.
| Half year ended | Quarter ended | |||||
|---|---|---|---|---|---|---|
| 30 June | 30 June | 30 June | 31 March | 30 June | ||
| 2019 | 2018 | 2019 | 2019 | 2018 | ||
| £m | £m | £m | £m | £m | ||
| Total income | 384 | 382 | 191 | 193 | 198 | |
| Operating expenses | (232) | (225) | (115) | (117) | (104) | |
| Impairment releases/(losses) | 3 | (1) | (1) | 4 | - | |
| Operating profit | 155 | 156 | 75 | 80 | 94 | |
| Return on equity | 16.6% | 15.8% | 15.9% | 17.1% | 19.3% | |
| Net interest margin | 2.48% | 2.53% | 2.44% | 2.52% | 2.54% | |
| Cost:income ratio | 60.4% | 58.9% | 60.2% | 60.6% | 52.5% | |
| As at | ||||||
| 30 June | 31 March | 31 December | ||||
| 2019 | 2019 | 2018 | ||||
| £bn | £bn | £bn | ||||
| Net loans to customers (amortised cost) | 14.7 | 14.4 | 14.3 | |||
| Customer deposits | 28.0 | 26.9 | 28.4 | |||
| RWAs | 9.7 | 9.6 | 9.4 | |||
| AUMs | 21.9 | 21.0 | 19.8 | |||
| Assets Under Administration (1) | 7.0 | 6.8 | 6.6 | |||
| Total Assets Under Management and Administration (AUMA) |
28.9 | 27.8 | 26.4 |
(1) Private Banking manages assets under management portfolios on behalf of UK PB and RBSI. Prior to Q4 2018, the assets under management portfolios of UK PB and RBSI were not included. Private Banking receives a management fee from UK PB and clients of RBSI in respect of providing this service.
● Total income reduced by £7 million, or 3.5%, due to lower non interest income as a result of a £4 million one-off benefit in Q2 2018 related to MIFID II and a £3 million one-off investment income charge in Q2 2019.
| Half year ended | Quarter ended | |||||
|---|---|---|---|---|---|---|
| 30 June 2019 |
30 June 2018 |
30 June 2019 |
31 March 2019 |
30 June 2018 |
||
| £m | £m | £m | £m | £m | ||
| Total income | 310 | 284 | 159 | 151 | 147 | |
| Operating expenses | (119) | (114) | (60) | (59) | (55) | |
| Impairment releases | 3 | 3 | 2 | 1 | 3 | |
| Operating profit | 194 | 173 | 101 | 93 | 95 | |
| Return on equity | 29.7% | 25.7% | 30.8% | 28.6% | 27.9% | |
| Net interest margin | 1.69% | 1.64% | 1.68% | 1.70% | 1.72% | |
| Cost:income ratio | 38.4% | 40.1% | 37.7% | 39.1% | 37.4% | |
| As at | ||||||
| 30 June | 31 March | 31 December | ||||
| 2019 | 2019 | 2018 | ||||
| £bn | £bn | £bn | ||||
| Net loans to customers (amortised cost) | 13.6 | 13.3 | 13.3 | |||
| Customer deposits | 28.1 | 27.6 | 27.5 | |||
| RWAs | 6.9 | 7.0 | 6.9 |
● Total expenses were £5 million, or 9.1%, higher following a £9 million litigation and conduct release in Q2 2018 partially offset by lower remediation spend.
| Half year ended | Quarter ended | ||||
|---|---|---|---|---|---|
| 30 June 2019 £m |
30 June 2018 £m |
30 June 2019 £m |
31 March 2019 £m |
30 June 2018 £m |
|
| Total income | 942 | 721 | 686 | 256 | 284 |
| of which: Core income excluding own credit adjustments | 702 | 728 | 325 | 377 | 316 |
| of which: Legacy income | 287 | (46) | 366 | (79) | (50) |
| Own credit adjustments | (47) | 39 | (5) | (42) | 18 |
| Operating expenses | (678) | (671) | (344) | (334) | (322) |
| Impairment releases/(losses) | 36 | (4) | 20 | 16 | (13) |
| Operating profit/(loss) | 300 | 46 | 362 | (62) | (51) |
| Return on equity | 1.0% | (0.5%) | 4.4% | (2.4%) | (3.0%) |
| Cost:income ratio | 72.0% | 93.1% | 50.1% | 130.5% | 113.4% |
| As at | |||||
| 30 June | 31 March | 31 December | |||
| 2019 | 2019 | 2018 | |||
| £bn | £bn | £bn | |||
| Funded assets | 133.4 | 138.8 | 111.4 | ||
| RWAs | 41.4 | 44.6 | 44.9 |
Note:
(1) The NatWest Markets operating segment is not the same as the NatWest Markets Plc legal entity or group. NatWest Markets Plc entity includes the Central items & other segment but excludes NatWest Markets N.V. for statutory reporting. Refer to NatWest Markets Plc and NatWest Markets N.V. interim results that were released on 2 August 2019 for further details.
| Half year ended | Quarter ended | ||||
|---|---|---|---|---|---|
| 30 June | 30 June | 30 June | 31 March | 30 June | |
| 2019 | 2018 | 2019 | 2019 | 2018 | |
| £m | £m | £m | £m | £m | |
| Central items not allocated | 284 | (979) | 337 | (53) | (850) |
● Central items not allocated represented a gain of £284 million in H1 2019 primarily reflecting FX recycling gains of £290 million and a legacy liability release of £256 million, both relating to the Alawwal merger, partially offset by strategic costs of £315 million. Other expenses decreased by £124 million compared with H1 2018 primarily due to one-off releases in H1 2019 and innovation and other costs that were held centrally in 2018 that are now allocated to the franchises.
The impact on profit of the Alawwal bank merger is summarised below:
| Segment | Legal entity | ||||
|---|---|---|---|---|---|
| NatWest | Central items & |
||||
| Markets | other | RBS | RBS | NWM N.V. | |
| £m | £m | £m | £m | £m | |
| Alawwal bank merger gain | 444 | - | 444 | (12) | 456 |
| Legacy liability release | - | 256 | 256 | 256 | - |
| FX recycling gain | - | 290 | 290 | 290 | - |
| Impact on non-interest income | 444 | 546 | 990 | 534 | 456 |
| Impact on RBS profit before tax | 990 | ||||
| Tax credit | 41 | ||||
| Profit after tax | 1,031 | ||||
| Attributable to: | |||||
| Ordinary shareholders | 757 | ||||
| Non-controlling interests | 274 |
| Business performance summary Capital and leverage ratios |
||
|---|---|---|
| The table below sets out the key Capital and Leverage ratios on an end-point basis. | End-point CRR basis (1) | |
| 30 June | 31 December | |
| 2019 | 2018 | |
| Capital adequacy ratios | % | % |
| CET1 | 16.0 | 16.2 |
| Tier 1 | 18.2 | 18.4 |
| Total | 20.9 | 21.8 |
| Capital | £m | £m |
| Tangible equity | 35,036 | 34,566 |
| Expected loss less impairment provisions | (726) | (654) |
| Prudential valuation adjustment | (419) | (494) |
| Deferred tax assets | (869) | (740) |
| Own credit adjustments | (261) | (405) |
| Pension fund assets | (400) | (394) |
| Cash flow hedging reserve | (117) | 191 |
| Foreseeable dividends | (2,053) | (1,326) |
| Other deductions | - | (105) |
| Total deductions | (4,845) | (3,927) |
| CET1 capital | 30,191 | 30,639 |
| AT1 capital | 4,051 | 4,051 |
| Tier 1 capital | 34,242 | 34,690 |
| Tier 2 capital | 5,119 | 6,483 |
| Total regulatory capital | 39,361 | 41,173 |
| Risk-weighted assets | ||
| Credit risk | 137,100 | 137,900 |
| Counterparty credit risk | 14,200 | 13,600 |
| Market risk | 14,600 | 14,800 |
| Operational risk | 22,600 | 22,400 |
| Total RWAs | 188,500 | 188,700 |
| Leverage | ||
| Cash and balances at central banks | 85,400 | 88,900 |
| Trading assets | 85,400 | 75,100 |
| Derivatives | 145,600 | 133,300 |
| Financial assets | 389,200 | 377,500 |
| Other assets | 24,300 | 19,400 |
| Total assets | 729,900 | 694,200 |
| Derivatives | ||
| - netting and variation margin | (156,600) | (141,300) |
| - potential future exposures | 44,100 | 42,100 |
(1) Based on end-point CRR Tier 1 capital and leverage exposure under the CRR Delegated Act.
Notes:
quarter of 2016.
(2) Based on end-point CRR Tier 1 capital and UK leverage exposures reflecting the post EU referendum measures announced by the Bank of England in the third
Securities financing transactions gross up 1,900 2,100 Undrawn commitments 49,300 50,300 Regulatory deductions and other adjustments (9,500) (2,900) CRR leverage exposure 659,100 644,500 CRR leverage ratio % 5.2 5.4 UK leverage exposure (2) 576,600 559,500 UK leverage ratio % (2) 5.9 6.2
| Half year ended 30 June 2019 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Personal & Ulster | Commercial & Private | Central | ||||||
| UK Personal | Ulster | Commercial | Private | RBS | NatWest | items & | Total RBS |
|
| Banking | Bank RoI | Banking | Banking | International | Markets | other (1) | ||
| £m | £m | £m | £m | £m | £m | £m | £m | |
| Income statement | ||||||||
| Net interest income | 2,084 | 200 | 1,424 | 261 | 242 | (122) | (85) | 4,004 |
| Non-interest income | 363 | 82 | 741 | 123 | 68 | 667 | 80 | 2,124 |
| Own credit adjustments | - | 1 | - | - | - | (47) | - | (46) |
| Strategic disposals | - | - | - | - | - | 444 | 591 | 1,035 |
| Total income | 2,447 | 283 | 2,165 | 384 | 310 | 942 | 586 | 7,117 |
| Direct expenses | ||||||||
| - staff costs |
(313) | (106) | (374) | (82) | (59) | (349) | (558) | (1,841) |
| - other costs |
(164) | (48) | (155) | (35) | (23) | (86) | (1,059) | (1,570) |
| Indirect expenses | (675) | (88) | (569) | (96) | (27) | (165) | 1,620 | - |
| Strategic costs | ||||||||
| - direct |
4 | (9) | (32) | - | (5) | (49) | (538) | (629) |
| - indirect |
(75) | (10) | (86) | (17) | (5) | (30) | 223 | - |
| Litigation and conduct costs | (6) | (20) | (46) | (2) | - | 1 | 13 | (60) |
| Operating expenses | (1,229) | (281) | (1,262) | (232) | (119) | (678) | (299) | (4,100) |
| Operating profit before impairment (losses)/releases | 1,218 | 2 | 903 | 152 | 191 | 264 | 287 | 3,017 |
| Impairment (losses)/releases | (181) | 21 | (202) | 3 | 3 | 36 | (3) | (323) |
| Operating profit | 1,037 | 23 | 701 | 155 | 194 | 300 | 284 | 2,694 |
| Additional information | ||||||||
| Return on equity (2) | 25.6% | 2.1% | 8.8% | 16.6% | 29.7% | 1.0% | nm | 12.1% |
| Cost:income ratio (2) | 50.2% | 99.3% | 56.9% | 60.4% | 38.4% | 72.0% | nm | 57.2% |
| Loan impairment rate (2) | 24bps | (21)bps | 39bps | nm | nm | nm | nm | 21bps |
| Impairment provisions (£bn) | (1.2) | (0.7) | (1.2) | - | - | (0.1) | - | (3.2) |
| Impairment provisions - stage 3 (£bn) |
(0.7) | (0.6) | (0.9) | - | - | (0.1) | - | (2.3) |
| Net interest margin | 2.57% | 1.63% | 1.98% | 2.48% | 1.69% | (0.73%) | nm | 1.83% |
| Third party customer asset rate | 3.28% | 2.30% | 3.20% | 2.95% | 1.75% | nm | nm | nm |
| Third party customer funding rate | (0.37%) | (0.17%) | (0.43%) | (0.44%) | (0.14%) | nm | nm | nm |
| Average interest earning assets (£bn) | 163.8 | 24.7 | 145.3 | 21.2 | 28.8 | 33.3 | 23.2 | 440.3 |
| Total assets (£bn) | 173.9 | 26.4 | 165.6 | 21.9 | 30.4 | 278.9 | 32.8 | 729.9 |
| Funded assets (£bn) | 173.9 | 26.4 | 165.6 | 21.9 | 30.4 | 133.4 | 32.7 | 584.3 |
| Net loans to customers - amortised cost (£bn) |
151.9 | 19.0 | 101.4 | 14.7 | 13.6 | 9.3 | 0.7 | 310.6 |
| Customer deposits (£bn) | 147.5 | 19.0 | 133.4 | 28.0 | 28.1 | 2.8 | 2.8 | 361.6 |
| Risk-weighted assets (RWAs) (£bn) | 37.0 | 14.2 | 77.8 | 9.7 | 6.9 | 41.4 | 1.5 | 188.5 |
| RWA equivalent (RWAes) (£bn) | 38.1 | 14.5 | 79.3 | 9.7 | 7.0 | 46.1 | 1.8 | 196.5 |
| Employee numbers (FTEs - thousands) |
21.3 | 3.1 | 10.5 | 1.9 | 1.8 | 5.0 | 23.0 | 66.6 |
For the notes to this table refer to page 18. nm = not meaningful
| Half year ended 30 June 2018 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Personal & Ulster | Commercial & Private | Central | ||||||
| UK Personal | Ulster | Commercial | Private | RBS | NatWest | items & | Total | |
| Banking | Bank RoI | Banking | Banking | International | Markets | other (1) |
RBS | |
| £m | £m | £m | £m | £m | £m | £m | £m | |
| Income statement | ||||||||
| Net interest income | 2,139 | 224 | 1,400 | 252 | 219 | 67 | 25 | 4,326 |
| Non-interest income | 412 | 88 | 990 | 130 | 65 | 615 | 37 | 2,337 |
| Own credit adjustments | - | - | - | - | - | 39 | - | 39 |
| Total income | 2,551 | 312 | 2,390 | 382 | 284 | 721 | 62 | 6,702 |
| Direct expenses | ||||||||
| - staff costs |
(360) | (98) | (374) | (83) | (51) | (309) | (628) | (1,903) |
| - other costs |
(117) | (45) | (114) | (28) | (33) | (115) | (1,229) | (1,681) |
| Indirect expenses | (708) | (88) | (597) | (105) | (37) | (201) | 1,736 | - |
| Strategic costs | ||||||||
| - direct |
(14) | 2 | (20) | (1) | - | (28) | (289) | (350) |
| - indirect |
(85) | (6) | (44) | (7) | (3) | (6) | 151 | - |
| Litigation and conduct costs | (7) | (17) | 9 | (1) | 10 | (12) | (783) | (801) |
| Operating expenses | (1,291) | (252) | (1,140) | (225) | (114) | (671) | (1,042) | (4,735) |
| Operating profit/(loss) before impairment (losses)/releases | 1,260 | 60 | 1,250 | 157 | 170 | 50 | (980) | 1,967 |
| Impairment (losses)/releases | (131) | 26 | (35) | (1) | 3 | (4) | 1 | (141) |
| Operating profit/(loss) | 1,129 | 86 | 1,215 | 156 | 173 | 46 | (979) | 1,826 |
| Additional information | ||||||||
| Return on equity (2) |
31.4% | 7.0% | 15.1% | 15.8% | 25.7% | (0.5%) | nm | 5.3% |
| Cost:income ratio (2) |
50.6% | 80.8% | 46.4% | 58.9% | 40.1% | 93.1% | nm | 70.4% |
| Loan impairment rate (2) | 18bps | (26)bps | 7bps | nm | nm | nm | nm | 9bps |
| Impairment provisions (£bn) | (1.1) | (1.1) | (1.5) | (0.1) | - | (0.2) | 0.1 | (3.9) |
| Impairment provisions - stage 3 (£bn) |
(0.7) | (1.0) | (1.3) | - | - | (0.1) | - | (3.1) |
| Net interest margin | 2.71% | 1.85% | 1.95% | 2.53% | 1.64% | 0.50% | nm | 2.02% |
| Third party customer asset rate | 3.38% | 2.39% | 2.93% | 2.85% | 2.44% | nm | nm | nm |
| Third party customer funding rate | (0.29%) | (0.21%) | (0.26%) | (0.18%) | (0.09%) | nm | nm | nm |
| Average interest earning assets (£bn) | 159.3 | 24.4 | 144.8 | 20.1 | 26.9 | 27.1 | 28.6 | 431.2 |
| Total assets (£bn) | 168.4 | 24.9 | 165.7 | 20.9 | 29.8 | 285.0 | 53.6 | 748.3 |
| Funded assets (£bn) | 168.4 | 24.8 | 165.7 | 20.9 | 29.8 | 134.5 | 53.1 | 597.2 |
| Net loans to customers - amortised cost (£bn) |
147.7 | 19.1 | 102.6 | 13.8 | 13.0 | 8.1 | (0.2) | 304.1 |
| Customer deposits (£bn) | 143.5 | 17.3 | 135.1 | 26.4 | 28.4 | 3.6 | 4.7 | 359.0 |
| Risk-weighted assets (RWAs) (£bn) | 32.0 | 16.8 | 83.1 | 9.4 | 6.8 | 50.1 | 0.6 | 198.8 |
| RWA equivalent (RWAes) (£bn) | 32.7 | 17.3 | 86.5 | 9.5 | 6.8 | 54.1 | 1.0 | 207.9 |
| Employee numbers (FTEs - thousands) |
23.4 | 3.1 | 10.7 | 1.9 | 1.7 | 5.6 | 23.6 | 70.0 |
For the notes to this table refer to page 18. nm = not meaningful.
| Quarter ended 30 June 2019 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Personal & Ulster | Commercial & Private | Central | ||||||
| UK Personal | Ulster | Commercial | Private | RBS | NatWest | items & | Total RBS |
|
| Banking | Bank RoI | Banking | Banking | International | Markets | other (1) | ||
| £m | £m | £m | £m | £m | £m | £m | £m | |
| Income statement | ||||||||
| Net interest income | 1,032 | 102 | 716 | 129 | 125 | (91) | (42) | 1,971 |
| Non-interest income | 170 | 35 | 367 | 62 | 34 | 338 | 71 | 1,077 |
| Own credit adjustments | - | 1 | - | - | - | (5) | 1 | (3) |
| Strategic disposals | - | - | - | - | - | 444 | 591 | 1,035 |
| Total income | 1,202 | 138 | 1,083 | 191 | 159 | 686 | 621 | 4,080 |
| Direct expenses | ||||||||
| - staff costs |
(155) | (54) | (184) | (41) | (31) | (176) | (264) | (905) |
| - other costs |
(90) | (22) | (80) | (17) | (10) | (38) | (511) | (768) |
| Indirect expenses | (297) | (41) | (260) | (45) | (13) | (76) | 732 | - |
| Strategic costs | ||||||||
| - direct |
4 | (4) | (12) | - | (3) | (31) | (388) | (434) |
| - indirect |
(49) | (5) | (50) | (10) | (3) | (17) | 134 | - |
| Litigation and conduct costs | (7) | (19) | (36) | (2) | - | (6) | 15 | (55) |
| Operating expenses | (594) | (145) | (622) | (115) | (60) | (344) | (282) | (2,162) |
| Operating profit/(loss) before impairment (losses)/releases | 608 | (7) | 461 | 76 | 99 | 342 | 339 | 1,918 |
| Impairment (losses)/releases | (69) | 10 | (197) | (1) | 2 | 20 | (2) | (237) |
| Operating profit | 539 | 3 | 264 | 75 | 101 | 362 | 337 | 1,681 |
| Additional information | ||||||||
| Return on equity (2) | 26.5% | 0.6% | 6.2% | 15.9% | 30.8% | 4.4% | nm | 15.8% |
| Cost:income ratio (2) | 49.4% | 105.1% | 56.1% | 60.2% | 37.7% | 50.1% | nm | 52.6% |
| Loan impairment rate (2) | 18bps | (20)bps | 77bps | nm | nm | nm | nm | 30bps |
| Impairment provisions (£bn) | (1.2) | (0.7) | (1.2) | - | - | (0.1) | - | (3.2) |
| Impairment provisions - stage 3 (£bn) |
(0.7) | (0.6) | (0.9) | - | - | (0.1) | - | (2.3) |
| Net interest margin |
2.51% | 1.62% | 1.97% | 2.44% | 1.68% | (1.05%) | nm | 1.78% |
| Third party customer asset rate | 3.25% | 2.29% | 3.18% | 2.89% | 1.79% | nm | nm | nm |
| Third party customer funding rate | (0.38%) | (0.15%) | (0.42%) | (0.45%) | (0.13%) | nm | nm | nm |
| Average interest earning assets (£bn) | 164.8 | 25.3 | 146.1 | 21.2 | 29.8 | 34.4 | 23.2 | 444.8 |
| Total assets (£bn) | 173.9 | 26.4 | 165.6 | 21.9 | 30.4 | 278.9 | 32.8 | 729.9 |
| Funded assets (£bn) | 173.9 | 26.4 | 165.6 | 21.9 | 30.4 | 133.4 | 32.7 | 584.3 |
| Net loans to customers - amortised cost (£bn) |
151.9 | 19.0 | 101.4 | 14.7 | 13.6 | 9.3 | 0.7 | 310.6 |
| Customer deposits (£bn) | 147.5 | 19.0 | 133.4 | 28.0 | 28.1 | 2.8 | 2.8 | 361.6 |
| Risk-weighted assets (RWAs) (£bn) | 37.0 | 14.2 | 77.8 | 9.7 | 6.9 | 41.4 | 1.5 | 188.5 |
| RWA equivalent (RWAes) (£bn) | 38.1 | 14.5 | 79.3 | 9.7 | 7.0 | 46.1 | 1.8 | 196.5 |
| Employee numbers (FTEs - thousands) |
21.3 | 3.1 | 10.5 | 1.9 | 1.8 | 5.0 | 23.0 | 66.6 |
For the notes to this table refer to page 18. nm = not meaningful
| Quarter ended 31 March 2019 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Personal & Ulster | Commercial & Private | Central | ||||||
| UK Personal | Ulster | Commercial | Private | RBS | NatWest | items & | Total RBS £m |
|
| Banking | Bank RoI | Banking £m |
Banking | International £m |
Markets £m |
other (1) £m |
||
| £m | £m | £m | ||||||
| Income statement | ||||||||
| Net interest income | 1,052 | 98 | 708 | 132 | 117 | (31) | (43) | 2,033 |
| Non-interest income | 193 | 47 | 374 | 61 | 34 | 329 | 9 | 1,047 |
| Own credit adjustments | - | - | - | - | - | (42) | (1) | (43) |
| Total income | 1,245 | 145 | 1,082 | 193 | 151 | 256 | (35) | 3,037 |
| Direct expenses | ||||||||
| - staff costs |
(158) | (52) | (190) | (41) | (28) | (173) | (294) | (936) |
| - other costs |
(74) | (26) | (75) | (18) | (13) | (48) | (548) | (802) |
| Indirect expenses | (378) | (47) | (309) | (51) | (14) | (89) | 888 | - |
| Strategic costs | ||||||||
| - direct |
- | (5) | (20) | - | (2) | (18) | (150) | (195) |
| - indirect |
(26) | (5) | (36) | (7) | (2) | (13) | 89 | - |
| Litigation and conduct costs | 1 | (1) | (10) | - | - | 7 | (2) | (5) |
| Operating expenses | (635) | (136) | (640) | (117) | (59) | (334) | (17) | (1,938) |
| Operating profit/(loss) before impairment (losses)/releases | 610 | 9 | 442 | 76 | 92 | (78) | (52) | 1,099 |
| Impairment (losses)/releases | (112) | 11 | (5) | 4 | 1 | 16 | (1) | (86) |
| Operating profit/(loss) |
498 | 20 | 437 | 80 | 93 | (62) | (53) | 1,013 |
| Additional information | ||||||||
| Return on equity (2) |
24.7% | 3.8% | 11.5% | 17.1% | 28.6% | (2.4%) | nm | 8.3% |
| Cost:income ratio (2) |
51.0% | 93.8% | 57.8% | 60.6% | 39.1% | 130.5% | nm | 63.4% |
| Loan impairment rate (2) | 30bps | (23)bps | 2bps | nm | nm | nm | nm | 11bps |
| Impairment provisions (£bn) | (1.2) | (0.7) | (1.0) | - | - | (0.1) | (0.1) | (3.1) |
| Impairment provisions - stage 3 (£bn) |
(0.6) | (0.6) | (0.8) | - | - | (0.1) | - | (2.1) |
| Net interest margin | 2.62% | 1.65% | 1.99% | 2.52% | 1.70% | (0.39%) | nm | 1.89% |
| Third party customer asset rate | 3.31% | 2.32% | 3.22% | 3.01% | 1.72% | nm | nm | nm |
| Third party customer funding rate | (0.37%) | (0.19%) | (0.47%) | (0.42%) | (0.15%) | nm | nm | nm |
| Average interest earning assets (£bn) | 162.9 | 24.1 | 144.6 | 21.2 | 27.8 | 32.1 | 23.1 | 435.8 |
| Total assets (£bn) | 172.2 | 24.8 | 165.4 | 21.7 | 28.9 | 272.8 | 33.3 | 719.1 |
| Funded assets (£bn) | 172.2 | 24.8 | 165.4 | 21.7 | 28.9 | 138.8 | 33.3 | 585.1 |
| Net loans to customers - amortised cost (£bn) |
150.6 | 18.2 | 100.8 | 14.4 | 13.3 | 9.1 | - | 306.4 |
| Customer deposits (£bn) | 145.7 | 17.5 | 131.8 | 26.9 | 27.6 | 2.7 | 3.0 | 355.2 |
| Risk-weighted assets (RWAs) (£bn) | 35.8 | 14.2 | 78.1 | 9.6 | 7.0 | 44.6 | 1.5 | 190.8 |
| RWA equivalent (RWAes) (£bn) | 36.8 | 14.2 | 79.9 | 9.6 | 7.1 | 49.1 | 2.0 | 198.7 |
| Employee numbers (FTEs - thousands) |
21.6 | 3.1 | 10.3 | 1.9 | 1.7 | 5.0 | 23.3 | 66.9 |
For the notes to this table refer to page 18. nm = not meaningful.
| Quarter ended 30 June 2018 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Personal & Ulster | Commercial & Private | Central | ||||||
| UK Personal | Ulster | Commercial | Private | RBS | NatWest | items & | Total | |
| Banking | Bank RoI | Banking £m |
Banking | International £m |
Markets £m |
other (1) £m |
RBS | |
| £m | £m | £m | £m | |||||
| Income statement | ||||||||
| Net interest income | 1,071 | 118 | 717 | 129 | 115 | 31 | (1) | 2,180 |
| Non-interest income | 182 | 48 | 515 | 69 | 32 | 235 | 121 | 1,202 |
| Own credit adjustments | - | - | - | - | - | 18 | - | 18 |
| Total income | 1,253 | 166 | 1,232 | 198 | 147 | 284 | 120 | 3,400 |
| Direct expenses | ||||||||
| - staff costs |
(182) | (49) | (186) | (40) | (27) | (144) | (311) | (939) |
| - other costs |
(52) | (26) | (67) | (14) | (18) | (62) | (623) | (862) |
| Indirect expenses | (334) | (41) | (286) | (50) | (17) | (99) | 827 | - |
| Strategic costs | ||||||||
| - direct |
(7) | 3 | (14) | - | - | (11) | (112) | (141) |
| - indirect |
(24) | (3) | (2) | 1 | (2) | - | 30 | - |
| Litigation and conduct costs | (6) | (8) | 10 | (1) | 9 | (6) | (780) | (782) |
| Operating expenses | (605) | (124) | (545) | (104) | (55) | (322) | (969) | (2,724) |
| Operating profit/(loss) before impairment (losses)/releases | 648 | 42 | 687 | 94 | 92 | (38) | (849) | 676 |
| Impairment (losses)/releases | (63) | 34 | (23) | - | 3 | (13) | (1) | (63) |
| Operating profit/(loss) | 585 | 76 | 664 | 94 | 95 | (51) | (850) | 613 |
| Additional information | ||||||||
| Return on equity (2) |
33.0% | 12.5% | 16.4% | 19.3% | 27.9% | (3.0%) | nm | 1.1% |
| Cost:income ratio (2) |
48.3% | 74.7% | 43.0% | 52.5% | 37.4% | 113.4% | nm | 80.0% |
| Loan impairment rate (2) | 17bps | (67)bps | 9bps | nm | nm | nm | nm | 8bps |
| Impairment provisions (£bn) | (1.1) | (1.1) | (1.5) | (0.1) | - | (0.2) | 0.1 | (3.9) |
| Impairment provisions - stage 3 |
(0.7) | (1.0) | (1.3) | - | - | (0.1) | - | (3.1) |
| Net interest margin (2) | 2.68% | 1.91% | 1.98% | 2.54% | 1.72% | 0.46% | nm | 2.01% |
| Third party customer asset rate |
3.36% | 2.40% | 2.96% | 2.82% | 2.34% | nm | nm | nm |
| Third party customer funding rate | (0.29%) | (0.21%) | (0.26%) | (0.17%) | (0.11%) | nm | nm | nm |
| Average interest earning assets (£bn) | 160.1 | 24.8 | 144.9 | 20.3 | 26.9 | 27.0 | 30.9 | 434.9 |
| Total assets (£bn) | 168.4 | 24.9 | 165.7 | 20.9 | 29.8 | 285.0 | 53.6 | 748.3 |
| Funded assets (£bn) | 168.4 | 24.8 | 165.7 | 20.9 | 29.8 | 134.5 | 53.1 | 597.2 |
| Net loans to customers - amortised cost (£bn) |
147.7 | 19.1 | 102.6 | 13.8 | 13.0 | 8.1 | (0.2) | 304.1 |
| Customer deposits (£bn) | 143.5 | 17.3 | 135.1 | 26.4 | 28.4 | 3.6 | 4.7 | 359.0 |
| Risk-weighted assets (RWAs) (£bn) | 32.0 | 16.8 | 83.1 | 9.4 | 6.8 | 50.1 | 0.6 | 198.8 |
| RWA equivalent (RWAes) (£bn) | 32.7 | 17.3 | 86.5 | 9.5 | 6.8 | 54.1 | 1.0 | 207.9 |
| Employee numbers (FTEs - thousands) |
23.4 | 3.1 | 10.7 | 1.9 | 1.7 | 5.6 | 23.6 | 70.0 |
nm = not meaningful.
Notes:
(1) Central items include unallocated transactions, including volatile items under IFRS, items related to Alawwal bank merger and RMBS related charges.
(2) Refer to Appendix 2 for details of basis of preparation and reconciliation of non-IFRS performance measures where relevant.
| Half year ended | |||
|---|---|---|---|
| 30 June | 30 June | ||
| 2019 | 2018* | ||
| £m | £m | ||
| Interest receivable | 5,553 | 5,444 | |
| Interest payable | (1,549) | (1,118) | |
| Net interest income | 4,004 | 4,326 | |
| Fees and commissions receivable | 1,762 | 1,646 | |
| Fees and commissions payable | (487) | (451) | |
| Income from trading activities | 599 | 847 | |
| Other operating income | 1,239 | 334 | |
| Non-interest income | 3,113 | 2,376 | |
| Total income | 7,117 | 6,702 | |
| Operating expenses | (4,100) | (4,735) | |
| Profit before impairment losses | 3,017 | 1,967 | |
| Impairment losses | (323) | (141) | |
| Operating profit before tax | 2,694 | 1,826 | |
| Tax charge | (194) | (709) | |
| Profit for the period | 2,500 | 1,117 | |
| Attributable to: | |||
| Ordinary shareholders | 2,038 | 888 | |
| Other owners | 202 | 245 | |
| Non-controlling interests | 260 | (16) | |
| Earnings per ordinary share | 16.9p | 7.4p | |
| Earnings per ordinary share - fully diluted | 16.8p | 7.4p |
* Restated. Refer to Note 2 for further details.
| Half year ended | ||
|---|---|---|
| 30 June | 30 June | |
| 2019 | 2018* | |
| £m | £m | |
| Profit for the period | 2,500 | 1,117 |
| Items that do not qualify for reclassification | ||
| Remeasurement of retirement benefit scheme | ||
| - contributions in preparation for ring-fencing (1) | - | (2,000) |
| - other movements | (68) | - |
| (Loss)/profit on fair value of credit in financial liabilities designated at FVTPL due to own credit risk | (96) | 95 |
| Fair value through other comprehensive income (FVOCI) financial assets | 38 | 3 |
| Tax | 26 | 500 |
| (100) | (1,402) | |
| Items that do qualify for reclassification | ||
| Fair value through other comprehensive income (FVOCI) financial assets | (12) | 199 |
| Cash flow hedges | 402 | (521) |
| Currency translation | (241) | 18 |
| Tax | (122) | 97 |
| 27 | (207) | |
| Other comprehensive loss after tax | (73) | (1,609) |
| Total comprehensive income/(loss) for the period | 2,427 | (492) |
| Attributable to: | ||
| Ordinary shareholders | 1,950 | (708) |
| Preference shareholders | 20 | 74 |
| Paid-in equity holders | 182 | 171 |
| Non-controlling interests | 275 | (29) |
| 2,427 | (492) |
* Restated. Refer to Note 2 for further details.
Note:
(1) On 17 April 2018, RBS agreed a Memorandum of Understanding (MoU) with the Trustees of the RBS Group Pension Fund in connection with the requirements of ring-fencing. NatWest Markets Plc could not continue to be a participant in the Main section and separate arrangements were required for its employees. Under the MoU, NatWest Plc made a contribution of £2 billion on 9 October 2018 to strengthen funding of the Main section in recognition of the changes in covenant. In Q1 2019, NatWest Markets Plc paid a contribution of £53 million to the new NatWest Markets section relating to the non-ring fenced bank.
| 30 June | 31 December | |
|---|---|---|
| 2019 £m |
2018 | |
| Assets | £m | |
| Cash and balances at central banks | 85,380 | 88,897 |
| Trading assets | 85,364 | 75,119 |
| Derivatives | 145,594 | 133,349 |
| Settlement balances | 8,438 | 2,928 |
| Loans to banks - amortised cost | 12,935 | 12,947 |
| Loans to customers - amortised cost | 310,631 | 305,089 |
| Other financial assets | 65,634 | 59,485 |
| Intangible assets | 6,631 | 6,616 |
| Other assets | 9,262 | 9,805 |
| Total assets | 729,869 | 694,235 |
| Liabilities | ||
| Bank deposits | 23,093 | 23,297 |
| Customer deposits | 361,626 | 360,914 |
| Settlement balances | 7,619 | 3,066 |
| Trading liabilities | 84,135 | 72,350 |
| Derivatives | 141,697 | 128,897 |
| Other financial liabilities | 46,485 | 39,732 |
| Subordinated liabilities | 9,808 | 10,535 |
| Other liabilities | 9,169 | 8,954 |
| Total liabilities | 683,632 | 647,745 |
| Equity | ||
| Ordinary shareholders' interests | 41,667 | 41,182 |
| Other owners' interests | 4,554 | 4,554 |
| Owners' equity | 46,221 | 45,736 |
| Non-controlling interests | 16 | 754 |
| Total equity | 46,237 | 46,490 |
| Total liabilities and equity | 729,869 | 694,235 |
| Half year ended | ||
|---|---|---|
| 30 June | 30 June | |
| 2019 | 2018 | |
| £m | £m | |
| Called-up share capital - at beginning of period | 12,049 | 11,965 |
| Ordinary shares issued | 42 | 63 |
| At end of period | 12,091 | 12,028 |
| Paid-in equity - at beginning and end of period | 4,058 | 4,058 |
| Share premium account - at beginning of period | 1,027 | 887 |
| Ordinary shares issued | 62 | 108 |
| At end of period | 1,089 | 995 |
| Merger reserve - at beginning and end of period | 10,881 | 10,881 |
| Fair value through other comprehensive income reserve - at beginning of period | 343 | 255 |
| Implementation of IFRS 9 on 1 January 2018 | - | 34 |
| Unrealised gains | 45 | 203 |
| Realised gains | (133) | (3) |
| Tax | 10 | (47) |
| At end of period | 265 | 442 |
| Cash flow hedging reserve - at beginning of period | (191) | 227 |
| Amount recognised in equity | 524 | (156) |
| Amount transferred from equity to earnings | (122) | (365) |
| Tax | (94) | 143 |
| At end of period | 117 | (151) |
| Foreign exchange reserve - at beginning of period | 3,278 | 2,970 |
| Retranslation of net assets | 30 | (58) |
| Foreign currency gains on hedges of net assets | 1 | 14 |
| Tax | 8 | 1 |
| Recycled to profit or loss on disposal of businesses (1) | (335) | 74 |
| At end of period | 2,982 | 3,001 |
| Retained earnings - at beginning of period | 14,312 | 17,130 |
| Implementation of IFRS 9 on 1 January 2018 | - | (105) |
| Implementation of IFRS 16 on 1 January 2019 (2) | (187) | - |
| Profit attributable to ordinary shareholders and other equity owners | 2,240 | 1,133 |
| Equity preference dividends paid | (20) | (74) |
| Paid-in equity dividends paid | (182) | (171) |
| Ordinary dividends paid | (1,327) | - |
| Realised gains in period on FVOCI equity shares | 114 | 3 |
| Remeasurement of retirement benefit schemes | ||
| - contributions in preparation for ring-fencing (3) | - | (2,000) |
| - other movements | (68) | - |
| - tax | 18 | 516 |
| Changes in fair value of credit in financial liabilities designated at fair value through profit or loss | ||
| - gross | (96) | 95 |
| - tax | 10 | (16) |
| Shares issued under employee share schemes | (4) | (2) |
| Share-based payments | (26) | 18 |
| At end of period | 14,784 | 16,527 |
For the notes to this table, refer to the following page.
| Half year ended | |||
|---|---|---|---|
| 30 June | 30 June | ||
| 2019 | 2018 | ||
| £m | £m | ||
| Own shares held - at beginning of period | (21) | (43) | |
| Purchase of own shares | (58) | (63) | |
| Shares issued under employee share schemes | 33 | 82 | |
| At end of period | (46) | (24) | |
| Owners' equity at end of period | 46,221 | 47,757 | |
| Non-controlling interests - at beginning of period | 754 | 763 | |
| Currency translation adjustments and other movements | 15 | (12) | |
| Profit/(loss) attributable to non-controlling interests | 260 | (16) | |
| Movements in fair value through other comprehensive income - unrealised losses | - | (1) | |
| Equity raised (4) | 45 | - | |
| Equity withdrawn and disposals (5) | (1,058) | - | |
| At end of period | 16 | 734 | |
| Total equity at end of period | 46,237 | 48,491 | |
| Total equity is attributable to: | |||
| Ordinary shareholders | 41,667 | 41,134 | |
| Preference shareholders | 496 | 2,565 | |
| Paid-in equity holders | 4,058 | 4,058 | |
| Non-controlling interests | 16 | 734 | |
| 46,237 | 48,491 |
Notes:
(1) Includes £338 million arising on the completion of the Alawwal bank merger in June 2019, of which £48 million relates to tax. The merger resulted in the derecognition of the associate investment in Alawwal bank and recognition of a new investment in SABB held at fair value through other comprehensive income (FVOCI). Further impacts in relation to the transaction are disclosed in Note 3 and 6.
(2) Refer to Note 2 for further information on the impact of IFRS 16 implementation.
(3) On 17 April 2018 RBS agreed a Memorandum of Understanding (MoU) with the Trustees of the RBS Group Pension Fund in connection with the requirements of ring-fencing. NatWest Markets Plc could not continue to be a participant in the Main section and separate arrangements were required for its employees. Under the MoU, NatWest Plc made a contribution of £2 billion on 9 October 2018 to strengthen funding of the Main section in recognition of the changes in covenant. In Q1 2019 NatWest Markets Plc paid a contribution of £53 million to the new NatWest Markets section relating to the non-ring fenced bank.
(4) Capital injection from RFS Holdings B.V. Consortium Members.
(5) Distribution to RFS Holdings B.V. Consortium Members on completion of the Alawwal bank merger.
| Half year ended | ||||
|---|---|---|---|---|
| 30 June 2019 |
30 June 2018 |
|||
| £m | £m | |||
| Operating activities | ||||
| Operating profit before tax | 2,694 | 1,826 | ||
| Adjustments for non-cash items | (2,428) | (1,280) | ||
| Net cash inflow from trading activities | 266 | 546 | ||
| Changes in operating assets and liabilities | 9,939 | 9,408 | ||
| Net cash flows from operating activities before tax | 10,205 | 9,954 | ||
| Income taxes paid | (192) | (156) | ||
| Net cash flows from operating activities | 10,013 | 9,798 | ||
| Net cash flows from investing activities | (5,776) | (3,769) | ||
| Net cash flows from financing activities | (2,689) | (2,307) | ||
| Effects of exchange rate changes on cash and cash equivalents | 211 | 38 | ||
| Net increase in cash and cash equivalents | 1,759 | 3,760 | ||
| Cash and cash equivalents at beginning of year | 108,811 | 122,605 | ||
| Cash and cash equivalents at end of year | 110,570 | 126,365 |
The Group condensed consolidated financial statements have been prepared in accordance with the Disclosure and Transparency Rules of the Financial Conduct Authority and IAS 34 'Interim Financial Reporting'. They should be read in conjunction with RBS's 2018 Annual Report and Accounts which were prepared in accordance with International Financial Reporting Standards issued by the International Accounting Standards Board (IASB) and interpretations issued by the IFRS Interpretations Committee of the IASB as adopted by the European Union (EU) (together IFRS).
The Group's business activities and financial position, and the factors likely to affect its future development and performance are discussed on pages 1 to 45. The risk factors which could materially affect the Group's future results are described on pages 46 and 47.
Having reviewed the Group's forecasts, projections and other relevant evidence, the directors have a reasonable expectation that the Group will continue in operational existence for the foreseeable future. Accordingly, the results for the half year ended 30 June 2019 have been prepared on a going concern basis.
Effective from 1 January 2019, Business Banking has been transferred from UK Personal and Business Banking (UK PBB) to Commercial Banking as the nature of the business, including distribution channels, products and customers, are more closely aligned to the Commercial Banking business. Concurrent with the transfer, UK PBB has been renamed UK Personal Banking (UK PB) and the previous franchise combining UK PBB (now UK PB) and Ulster Bank RoI has been renamed Personal & Ulster. Comparatives have been re-stated. Refer to Note 4, Segmental analysis and the disclosures in the Capital and risk management section, as marked, where the impact is reflected.
The Group's principal accounting policies are as set out on pages 182 to 186 of the 2018 Annual Report and Accounts and are unchanged other than as presented below.
IAS 12 'Income taxes' was revised with effect from 1 January 2019. The income statement is now required to include any tax relief on the servicing cost of instruments classified as equity. Relief of £67 million was recognised in the statement of changes in equity for the year ended 31 December 2018; this and prior periods have been restated.
Until 1 January 2019, interest in suspense recoveries were presented as a component of interest receivable within Net interest income. It amounted to £31 million for the period ended 30 June 2019. From 1 January 2019 interest in suspense recoveries is presented within impairment charges; prior periods were presented as income. Comparatives have not been restated.
The Group has adopted IFRS 16 'Leases' with effect from 1 January 2019, replacing IAS 17 'Leases'. The Group has applied IFRS 16 on a modified retrospective basis without restating prior years. Accounting policy 10 presented in the 2018 Annual Report and Accounts has been updated as follows:
Finance lease contracts are those which transfer substantially all the risks and rewards of ownership of an asset to a customer. All other contracts with customers to lease assets are classified as operating leases.
Loans to customers include finance lease receivables measured at the net investment in the lease, comprising the minimum lease payments and any unguaranteed residual value discounted at the interest rate implicit in the lease. Interest receivable includes finance lease income recognised at a constant periodic rate of return before tax on the net investment. Unguaranteed residual values are subject to regular review; if there is a reduction in their value, income allocation is revised and any reduction in respect of amounts accrued is recognised immediately.
Rental income from operating leases is recognised in other operating income on a straight-line basis over the lease term unless another systematic basis better represents the time pattern of the asset's use. Operating lease assets are included within Property, plant and equipment and depreciated over their useful lives.
On entering a new lease contract, the Group recognises a right of use asset and a liability to pay future rentals. The liability is measured at the present value of future lease payments discounted at the applicable incremental borrowing rate. The right of use asset is depreciated over the shorter of the term of the lease and the useful economic life, subject to review for impairment. Short term and low value leased assets are expensed on a systematic basis.
For further details see page 186 of RBS's 2018 Annual Report and Accounts. The impact on RBS's balance sheet at 1 January 2019 is as follows:
| £bn | |
|---|---|
| Retained earnings at 1 January 2019 | 14.3 |
| Loans to customers - Finance leases | 0.2 |
| Other assets - Net right of use assets | 1.3 |
| - Recognition of lease liabilities | (1.9) |
| - Provision for onerous leases | 0.2 |
| Other liabilities | (1.7) |
| Net impact on retained earnings | (0.2) |
| Retained earnings at 1 January 2019 | 14.1 |
Operating lease commitments reported under IAS 17 were £2.7 billion which resulted in lease liabilities recognised under IFRS 16 of £1.9 billion. The difference is primarily because of the different treatment of termination and extension options; and discounting the contractual lease payments under IFRS 16.
The judgements and assumptions that are considered to be the most important to the portrayal of the Group's financial condition are those relating to goodwill, provisions for liabilities, deferred tax, loan impairment provisions and fair value of financial instruments. These critical accounting policies and judgements are described on page 186 of the 2018 Annual Report and Accounts.
| Half year ended | |||
|---|---|---|---|
| 30 June | 30 June | ||
| 2019 | 2018 | ||
| £m | £m | ||
| Loans to customers - amortised cost | 4,848 | 4,978 | |
| Loans to banks - amortised cost | 346 | 236 | |
| Other financial assets | 359 | 230 | |
| Interest receivable | 5,553 | 5,444 | |
| Balances by banks | 144 | 113 | |
| Customer deposits | 599 | 415 | |
| Other financial liabilities | 481 | 337 | |
| Subordinated debt | 245 | 226 | |
| Internal funding of trading businesses | 80 | 27 | |
| Interest payable | 1,549 | 1,118 | |
| Net interest income (1) | 4,004 | 4,326 | |
| Net fees and commissions | 1,275 | 1,195 | |
| Foreign exchange | 219 | 336 | |
| Interest rate | 397 | 275 | |
| Credit | 31 | 187 | |
| Own credit adjustment | (46) | 39 | |
| Equities, commodities and other | (2) | 10 | |
| Income from trading activities | 599 | 847 | |
| Operating lease and other rental income | 127 | 128 | |
| Changes in the fair value of financial assets and liabilities designated as at fair value through profit or loss | 19 | (7) | |
| Changes in fair value of other financial assets fair value through profit or loss | 31 | (42) | |
| Hedge ineffectiveness | 21 | (69) | |
| Loss on disposal of amortised cost assets | - | 22 | |
| Profit on disposal of fair value through other comprehensive income assets | 16 | 1 | |
| Profit on sale of property, plant and equipment | 15 | 21 | |
| Share of (loss)/profits of associated entities | (22) | 17 | |
| Profit/(loss) on disposal of subsidiaries and associates (2) | 1,037 | (9) | |
| Other income | (5) | 272 | |
| Other operating income | 1,239 | 334 | |
| Total non-interest income | 3,113 | 2,376 | |
| Total income | 7,117 | 6,702 | |
| Salaries | (1,455) | (1,520) | |
| Variable compensation | (185) | (148) | |
| Social security costs | (156) | (158) | |
| Pension costs | (162) | (169) | |
| Other | (70) | (91) | |
| Staff costs | (2,028) | (2,086) | |
| Premises and equipment | (558) | (644) | |
| Depreciation and amortisation (3) | (621) | (338) | |
| Other administrative expenses (4) | (863) | (1,636) | |
| Administrative expenses | (2,042) | (2,618) | |
| Write down of goodwill and other intangible assets | (30) | (31) | |
| Operating expenses | (4,100) | (4,735) | |
| Impairment losses | (323) | (141) | |
| Impairments as a % of gross loans to customers | 0.21% | 0.09% |
Notes:
(1) Negative interest on loans is reported as interest payable. Negative interest on customer deposits is reported as interest receivable.
(2) Includes a gain of £444 million (€523 million), a legacy liability release of £256 million and an FX recycling gain of £290 million on completion of the Alawwal bank merger.
(3) Half year ended 30 June 2019 includes a property impairment of £133 million and accelerated depreciation of £66 million in relation to the planned reduction of the Group property portfolio and depreciation charges in relation to the right of use assets recognised following the adoption of IFRS 16 (previously leasing costs in relation to these were included in premises and equipment). For further details on the adoption of IFRS 16 refer to Note 2.
(4) Includes litigation and conduct costs, net of amounts recovered. Refer to Note 9 for further details.
The business is organised into the following franchises and reportable segments:
The following tables provide a segmental analysis of operating profit/(loss) by main income statement captions.
| Half year ended 30 June 2019 | Net interest £m |
Net fees and income commissions £m |
Other non- interest income £m |
Total income £m |
Operating expenses £m |
Impairment (losses)/ releases £m |
Operating profit/(loss) £m |
|---|---|---|---|---|---|---|---|
| UK Personal Banking Ulster Bank RoI |
2,084 200 |
366 51 |
(3) 32 |
2,447 283 |
(1,229) (281) |
(181) 21 |
1,037 23 |
| Personal & Ulster | 2,284 | 417 | 29 | 2,730 | (1,510) | (160) | 1,060 |
| Commercial Banking Private Banking |
1,424 261 |
661 111 |
80 12 |
2,165 384 |
(1,262) (232) |
(202) 3 |
701 155 |
| Commercial & Private Banking | 1,685 | 772 | 92 | 2,549 | (1,494) | (199) | 856 |
| RBS International NatWest Markets Central items & other |
242 (122) (85) |
53 48 (15) |
15 1,016 686 |
310 942 586 |
(119) (678) (299) |
3 36 (3) |
194 300 284 |
| Total | 4,004 | 1,275 | 1,838 | 7,117 | (4,100) | (323) | 2,694 |
| Half year ended 30 June 2018* | |||||||
| UK Personal Banking Ulster Bank RoI |
2,139 224 |
359 43 |
53 45 |
2,551 312 |
(1,291) (252) |
(131) 26 |
1,129 86 |
| Personal & Ulster | 2,363 | 402 | 98 | 2,863 | (1,543) | (105) | 1,215 |
| Commercial Banking Private Banking |
1,400 252 |
631 116 |
359 14 |
2,390 382 |
(1,140) (225) |
(35) (1) |
1,215 156 |
| Commercial & Private Banking | 1,652 | 747 | 373 | 2,772 | (1,365) | (36) | 1,371 |
| RBS International NatWest Markets Central items & other |
219 67 25 |
52 (7) 1 |
13 661 36 |
284 721 62 |
(114) (671) (1,042) |
3 (4) 1 |
173 46 (979) |
| Total | 4,326 | 1,195 | 1,181 | 6,702 | (4,735) | (141) | 1,826 |
* Restated. Refer to Note 1 for further details.
| Half year ended | |||||||
|---|---|---|---|---|---|---|---|
| 30 June 2019 | 30 June 2018* | ||||||
| Inter | Inter | ||||||
| External | segment | Total | External | segment | Total | ||
| Total revenue | £m | £m | £m | £m | £m | £m | |
| UK Personal Banking | 3,118 | 32 | 3,150 | 3,096 | 30 | 3,126 | |
| Ulster Bank RoI | 309 | 2 | 311 | 339 | - | 339 | |
| Personal & Ulster | 3,427 | 34 | 3,461 | 3,435 | 30 | 3,465 | |
| Commercial Banking | 2,173 | 63 | 2,236 | 2,354 | 42 | 2,396 | |
| Private Banking | 343 | 120 | 463 | 333 | 88 | 421 | |
| Commercial & Private Banking | 2,516 | 183 | 2,699 | 2,687 | 130 | 2,817 | |
| RBS International | 319 | 15 | 334 | 235 | 79 | 314 | |
| NatWest Markets | 1,494 | 510 | 2,004 | 953 | 259 | 1,212 | |
| Central items & other | 1,397 | (742) | 655 | 961 | (498) | 463 | |
| Total | 9,153 | - | 9,153 | 8,271 | - | 8,271 |
* Restated. Refer to Note 1 for further details.
4. Segmental analysis continued
Analysis of net fees and commissions
| Personal & Ulster | Commercial & Private | Central | ||||||
|---|---|---|---|---|---|---|---|---|
| UK Personal | Ulster | Commercial | Private | RBS | NatWest | items | ||
| Banking Bank RoI | Banking | Banking | International | Markets | & other | Total | ||
| Half year ended 30 June 2019 | £m | £m | £m | £m | £m | £m | £m | £m |
| Fees and commissions receivable | ||||||||
| - Lending (credit facilities) | 266 | 18 | 204 | 1 | 18 | 35 | - | 542 |
| - Payment services | 154 | 21 | 323 | 17 | 12 | 15 | - | 542 |
| - Credit and debit card fees | 189 | 10 | 84 | 6 | 1 | - | - | 290 |
| - Underwriting fees | - | - | - | - | - | 100 | - | 100 |
| - Investment management, | ||||||||
| trustee and fiduciary services | 22 | 2 | 3 | 91 | 20 | - | - | 138 |
| - Other | 36 | 6 | 82 | 12 | 3 | 88 | (77) | 150 |
| Total | 667 | 57 | 696 | 127 | 54 | 238 | (77) | 1,762 |
| Fees and commissions payable | (301) | (6) | (35) | (16) | (1) | (190) | 62 | (487) |
| Net fees and commissions | 366 | 51 | 661 | 111 | 53 | 48 | (15) | 1,275 |
| Half year ended 30 June 2018* | ||||||||
| Fees and commissions receivable | ||||||||
| - Lending (credit facilities) | 208 | 15 | 183 | 1 | 17 | 39 | - | 463 |
| - Payment services | 101 | 12 | 267 | 17 | 11 | 1 | - | 409 |
| - Credit and debit card fees | 222 | 12 | 86 | 6 | - | - | - | 326 |
| - Underwriting fees | - | - | 22 | - | - | 93 | - | 115 |
| - Investment management, | ||||||||
| trustee and fiduciary services | 25 | 2 | - | 95 | 21 | - | - | 143 |
| - Other | 37 | 5 | 99 | 12 | 3 | 90 | (56) | 190 |
| Total | 593 | 46 | 657 | 131 | 52 | 223 | (56) | 1,646 |
| Fees and commissions payable | (234) | (3) | (26) | (15) | - | (230) | 57 | (451) |
| Net fees and commissions | 359 | 43 | 631 | 116 | 52 | (7) | 1 | 1,195 |
* Restated. Refer to Note 1 for further details.
| 30 June 2019 | 31 December 2018* | |||||
|---|---|---|---|---|---|---|
| Assets | Liabilities | Assets | Liabilities | |||
| £m | £m | £m | £m | |||
| UK Personal Banking | 173,860 | 150,573 | 171,011 | 148,793 | ||
| Ulster Bank RoI | 26,430 | 21,933 | 25,193 | 21,189 | ||
| Personal & Ulster | 200,290 | 172,506 | 196,204 | 169,982 | ||
| Commercial Banking | 165,594 | 139,098 | 166,478 | 139,803 | ||
| Private Banking | 21,909 | 28,188 | 21,983 | 28,554 | ||
| Commercial & Private Banking | 187,503 | 167,286 | 188,461 | 168,357 | ||
| RBS International | 30,413 | 28,325 | 28,398 | 27,663 | ||
| NatWest Markets | 278,949 | 261,084 | 244,531 | 227,399 | ||
| Central items & other | 32,714 | 54,431 | 36,641 | 54,344 | ||
| Total | 729,869 | 683,632 | 694,235 | 647,745 |
* Restated. Refer to Note 1 for further details.
The actual tax charge differs from the expected tax charge computed by applying the standard UK corporation tax rate of 19% (2018 - 19%), as analysed below.
| Half year ended | ||
|---|---|---|
| 30 June 2019 £m |
30 June 2018 £m |
|
| Profit before tax | 2,694 | 1,826 |
| Expected tax charge | (512) | (347) |
| Losses and temporary differences in period where no deferred tax assets recognised | (2) | (8) |
| Foreign profits taxed at other rates | 5 | 1 |
| Items not allowed for tax | ||
| - losses on disposals and write-downs | (46) | (26) |
| - UK bank levy | (15) | (16) |
| - regulatory and legal actions | (5) | (154) |
| - other disallowable items | (40) | (34) |
| Non-taxable items | ||
| - Alawwal bank merger gain disposal | 212 | - |
| - other | 26 | 8 |
| Taxable foreign exchange movements | - | (5) |
| Losses brought forward and utilised | 21 | 18 |
| Increase/(reduction) in carrying value of deferred tax in respect of UK losses | 215 | (15) |
| Banking surcharge | (155) | (188) |
| Tax credit paid-in equity | - | 32 |
| Adjustments in respect of prior periods | 102 | 25 |
| Actual tax charge | (194) | (709) |
The tax charge includes a £215 million deferred tax asset credit associated with the transfer of taxable losses from NatWest Markets Plc to RBS Plc under ring-fencing regulations.
At 30 June 2019, the Group has recognised a deferred tax asset of £1,499 million (31 December 2018 - £1,412 million) and a deferred tax liability of £463 million (31 December 2018 - £454 million). These include amounts recognised in respect of UK trading losses of £848 million (31 December 2018 - £675 million). Under UK tax legislation, these UK losses can be carried forward indefinitely. The Finance Act 2016 limited the offset of the UK banking losses carried forward to 25% of taxable profits. The Group has considered the carrying value of this asset as at 30 June 2019 and concluded that it is recoverable based on future profit projections.
| Half year ended | ||
|---|---|---|
| 30 June | 30 June 2018 |
|
| 2019 £m |
||
| £m | ||
| RFS Holdings B.V. Consortium Members (1) | 258 | (17) |
| Other | 2 | 1 |
| Profit/(loss) attributable to non-controlling interests | 260 | (16) |
Note:
(1) Includes a gain of £274 million recognised on completion of the Alawwal Bank merger.
Trading assets and liabilities comprise assets and liabilities held at fair value in trading portfolios.
| 30 June | 31 December | |
|---|---|---|
| 2019 | 2018 | |
| Assets | £m | £m |
| Loans | ||
| Reverse repos | 28,176 | 24,759 |
| Collateral given | 22,063 | 19,036 |
| Other loans | 1,651 | 1,308 |
| Total loans | 51,890 | 45,103 |
| Securities | ||
| Central and local government | ||
| - UK | 5,365 | 6,834 |
| - US | 6,093 | 4,689 |
| - other | 16,341 | 13,498 |
| Other securities | 5,675 | 4,995 |
| Total securities | 33,474 | 30,016 |
| Total | 85,364 | 75,119 |
| Liabilities | ||
| Deposits | ||
| Repos | 32,087 | 25,645 |
| Collateral received | 23,204 | 20,187 |
| Other deposits | 2,335 | 1,788 |
| Total deposits | 57,626 | 47,620 |
| Debt securities in issue | 1,495 | 903 |
| Short positions | 25,014 | 23,827 |
| Total | 84,135 | 72,350 |
The following tables analyse financial assets and liabilities in accordance with the categories of financial instruments in IFRS 9. Assets and liabilities outside the scope of IFRS 9 are shown within other assets and other liabilities.
| Amortised | Other | ||||
|---|---|---|---|---|---|
| MFVTPL (1,2) | FVOCI (3) | cost | assets | Total | |
| Assets | £m | £m | £m | £m | £m |
| Cash and balances at central banks | - | - | 85,380 | 85,380 | |
| Trading assets | 85,364 | - | 85,364 | ||
| Derivatives | 145,594 | 145,594 | |||
| Settlement balances | - | - | 8,438 | 8,438 | |
| Loans to banks - amortised cost | 12,935 | 12,935 | |||
| Loans to customers - amortised cost | 310,631 | 310,631 | |||
| Other financial assets | 1,130 | 51,250 | 13,254 | 65,634 | |
| Intangible assets | - | - | - | 6,631 | 6,631 |
| Other assets | 9,262 | 9,262 | |||
| 30 June 2019 | 232,088 | 51,250 | 430,638 | 15,893 | 729,869 |
| Cash and balances at central banks | - | - | 88,897 | 88,897 | |
| Trading assets | 75,119 | - | 75,119 | ||
| Derivatives | 133,349 | 133,349 | |||
| Settlement balances | - | - | 2,928 | 2,928 | |
| Loans to banks - amortised cost | 12,947 | 12,947 | |||
| Loans to customers - amortised cost | 305,089 | 305,089 | |||
| Other financial assets | 1,638 | 46,077 | 11,770 | 59,485 | |
| Intangible assets | - | - | - | 6,616 | 6,616 |
| Other assets | 9,805 | 9,805 | |||
| 31 December 2018 | 210,106 | 46,077 | 421,631 | 16,421 | 694,235 |
| Liabilities | Held-for- trading (1) £m |
DFV (4) £m |
Amortised cost £m |
Other liabilities £m |
Total £m |
|---|---|---|---|---|---|
| Bank deposits | - | - | 23,093 | 23,093 | |
| Customer deposits | - | - | 361,626 | 361,626 | |
| Settlement balances | - | - | 7,619 | 7,619 | |
| Trading liabilities | 84,135 | - | 84,135 | ||
| Derivatives | 141,697 | - | 141,697 | ||
| Other financial liabilities | - | 2,494 | 43,991 | 46,485 | |
| Subordinated liabilities | - | 763 | 9,045 | 9,808 | |
| Other liabilities | - | - | 2,146 | 7,023 | 9,169 |
| 30 June 2019 | 225,832 | 3,257 | 447,520 | 7,023 | 683,632 |
| Bank deposits | - | - | 23,297 | 23,297 | |
| Customer deposits | - | - | 360,914 | 360,914 | |
| Settlement balances | - | - | 3,066 | 3,066 | |
| Trading liabilities | 72,350 | - | 72,350 | ||
| Derivatives | 128,897 | - | 128,897 | ||
| Other financial liabilities | - | 2,840 | 36,892 | 39,732 | |
| Subordinated liabilities | - | 867 | 9,668 | 10,535 | |
| Other liabilities | - | - | 2,218 | 6,736 | 8,954 |
| 31 December 2018 | 201,247 | 3,707 | 436,055 | 6,736 | 647,745 |
Notes:
(1) Includes derivatives held for hedging purposes.
(2) Mandatory fair value through profit or loss.
(3) Fair value through other comprehensive income.
(4) Designated as at fair value through profit or loss.
The Group's financial assets and liabilities include:
| 30 June | 31 December | |
|---|---|---|
| 2019 | 2018 | |
| £m | £m | |
| Reverse repos | ||
| Loans to banks - amortised cost | 2,162 | 3,539 |
| Loans to customers - amortised cost | 683 | 9 |
| Trading assets | 28,176 | 24,759 |
| Repos | ||
| Bank deposits | 3,715 | 941 |
| Customer deposits | 1,004 | 3,774 |
| Trading liabilities | 32,087 | 25,645 |
Disclosures relating to the control environment, valuation techniques and related aspects pertaining to financial instruments measured at fair value are included in the 2018 Annual Report and Accounts. Valuation, sensitivity methodologies and inputs at 30 June 2019 are consistent with those described in Note 12 to the 2018 Annual Report and Accounts.
The tables below show financial instruments carried at fair value on the balance sheet by valuation hierarchy - level 1, level 2 and level 3 and valuation sensitivities for level 3 balances.
| 30 June 2019 | 31 December 2018 | |||||
|---|---|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Level 1 | Level 2 | Level 3 | |
| £m | £m | £m | £m | £m | £m | |
| Assets | ||||||
| Trading assets | ||||||
| Loans | - | 51,616 | 274 | - | 44,983 | 120 |
| Securities | 24,247 | 8,885 | 342 | 22,003 | 7,312 | 701 |
| Derivatives | 5 | 143,994 | 1,595 | - | 131,513 | 1,836 |
| Other financial assets | ||||||
| Loans | - | 425 | 63 | - | 768 | 136 |
| Securities | 43,434 | 8,014 | 444 | 40,132 | 6,172 | 507 |
| Total financial assets held at fair value | 67,686 | 212,934 | 2,718 | 62,135 | 190,748 | 3,300 |
| Liabilities | ||||||
| Trading liabilities | ||||||
| Deposits | - | 57,258 | 368 | - | 47,243 | 377 |
| Debt securities in issue | - | 1,415 | 80 | - | 791 | 112 |
| Short positions | 19,656 | 5,358 | - | 18,941 | 4,886 | - |
| Derivatives | 4 | 140,507 | 1,186 | - | 127,709 | 1,188 |
| Other financial liabilities | ||||||
| Debt securities in issue | - | 2,234 | 156 | - | 2,348 | 280 |
| Other deposits | - | 104 | - | - | 212 | - |
| Subordinated liabilities | - | 763 | - | - | 867 | - |
| Total financial liabilities held at fair value | 19,660 | 207,639 | 1,790 | 18,941 | 184,056 | 1,957 |
Notes:
(1) Level 1 – Instruments valued using unadjusted quoted prices in active and liquid markets for identical financial instruments. Examples include government bonds, listed equity shares and certain exchange-traded derivatives.
Level 2 - Instruments valued using valuation techniques that have observable inputs. Examples include most government agency securities, investment-grade corporate bonds, certain mortgage products, including CLOs, most bank loans, repos and reverse repos, less liquid listed equities, state and municipal obligations, most notes issued, and certain money market securities and loan commitments and most OTC derivatives. Level 3 - Instruments valued using a valuation technique where at least one input which could have a significant effect on the instrument's valuation, is not
based on observable market data. Examples include cash instruments which trade infrequently, certain syndicated and commercial mortgage loans, certain emerging markets and derivatives with unobservable model inputs.
(2) Transfers between levels are deemed to have occurred at the beginning of the quarter in which the instruments were transferred. There were no significant transfers between level 1 and level 2.
8. Financial instruments: carried at fair value - valuation hierarchy continued
| 30 June 2019 | 31 December 2018 | ||||||
|---|---|---|---|---|---|---|---|
| Level 3 Favourable Unfavourable |
Level 3 | Favourable | Unfavourable | ||||
| £m | £m | £m | £m | £m | £m | ||
| Assets | |||||||
| Trading assets | |||||||
| Loans | 274 | 10 | (10) | 120 | 10 | (10) | |
| Securities | 342 | 10 | - | 701 | 20 | (10) | |
| Derivatives | |||||||
| Interest rate | 1,326 | 200 | (200) | 1,487 | 120 | (120) | |
| Foreign exchange | 123 | 10 | (10) | 130 | 10 | (10) | |
| Other | 146 | 10 | (10) | 219 | 10 | (20) | |
| Other financial assets | |||||||
| Loans | 63 | - | - | 136 | 10 | (20) | |
| Securities | 444 | 40 | (30) | 507 | 50 | (30) | |
| Total financial assets held at fair value | 2,718 | 280 | (260) | 3,300 | 230 | (220) | |
| Liabilities | |||||||
| Trading liabilities | |||||||
| Deposits | 368 | 40 | (40) | 377 | 40 | (40) | |
| Debt securities in issue | 80 | - | - | 112 | 10 | (10) | |
| Derivatives | |||||||
| Interest rate | 802 | 100 | (100) | 808 | 70 | (70) | |
| Foreign exchange | 304 | 10 | (10) | 279 | 10 | (10) | |
| Other | 80 | - | - | 101 | - | (10) | |
| Other financial liabilities | |||||||
| Debt securities in issue | 156 | - | - | 280 | 10 | (10) | |
| Total financial liabilities held at fair value | 1,790 | 150 | (150) | 1,957 | 140 | (150) |
| Half year ended 2019 | Half year ended 2018 | |||||||
|---|---|---|---|---|---|---|---|---|
| Other | Other | |||||||
| Trading | financial | Total | Total | Trading | financial | Total | Total | |
| assets (2) | assets (3) | assets | liabilities | assets (2) | assets (3) | assets | liabilities | |
| £m | £m | £m | £m | £m | £m | £m | £m | |
| At 1 January | 2,657 | 643 | 3,300 | 1,957 | 2,692 | 530 | 3,222 | 2,187 |
| Amount recorded in the income statement (1) | (113) | 4 | (109) | 260 | (21) | 64 | 43 | (233) |
| Amount recorded in the statement of | ||||||||
| comprehensive income | - | 75 | 75 | - | - | 17 | 17 | - |
| Level 3 transfers in | 158 | 2 | 160 | 161 | 513 | 84 | 597 | 198 |
| Level 3 transfers out | (462) | (53) | (515) | (239) | (181) | (1) | (182) | (107) |
| Issuances | - | - | - | 23 | - | - | - | 24 |
| Purchases | 290 | 2 | 292 | 216 | 596 | 17 | 613 | 191 |
| Settlements | (73) | (6) | (79) | (171) | (473) | - | (473) | (108) |
| Sales | (249) | (157) | (406) | (419) | (632) | (79) | (711) | (122) |
| Foreign exchange and other adjustments | 3 | (3) | - | 2 | 1 | 2 | 3 | - |
| At 30 June | 2,211 | 507 | 2,718 | 1,790 | 2,495 | 634 | 3,129 | 2,030 |
| Amounts recorded in the income statement | ||||||||
| in respect of balances held at year end | ||||||||
| - unrealised | (112) | 2 | (110) | 260 | (16) | 24 | 8 | (222) |
| - realised | - | - | - | - | 5 | 4 | 9 | 7 |
Notes:
(1) There were £383 million net losses on trading assets and liabilities (30 June 2018 - £195 million gains) recorded in income from trading activities. Net gains on other instruments of £14 million (30 June 2018 - £81 million gains) were recorded in other operating income and interest income as appropriate.
(2) Trading assets comprise assets held at fair value in trading portfolios.
(3) Other financial assets comprise fair value through other comprehensive income, designated at fair value through profit or loss and other fair value through profit or loss.
The following table shows the carrying value and fair value of financial instruments carried at amortised cost on the balance sheet.
| Items where fair value approximates |
Fair value hierarchy level | |||||
|---|---|---|---|---|---|---|
| carrying value Carrying value | Fair value | Level 1 | Level 2 | Level 3 | ||
| 30 June 2019 | £bn | £bn | £bn | £bn | £bn | £bn |
| Financial assets | ||||||
| Cash and balances at central banks | 85.4 | |||||
| Settlement balances | 8.4 | |||||
| Loans to banks | 0.2 | 12.7 | 12.7 | - | 4.9 | 7.8 |
| Loans to customers | 310.6 | 307.4 | - | 1.0 | 306.4 | |
| Other financial assets | ||||||
| Securities | 13.3 | 13.5 | 7.2 | 4.1 | 2.2 | |
| Financial liabilities | ||||||
| Bank deposits | 4.2 | 18.9 | 18.7 | - | 12.7 | 6.0 |
| Customer deposits | 307.2 | 54.4 | 54.5 | - | 7.4 | 47.1 |
| Settlement balances | 7.6 | |||||
| Other financial liabilities | ||||||
| Debt securities in issue | 44.0 | 45.9 | - | 43.7 | 2.2 | |
| Subordinated liabilities | 9.0 | 10.1 | - | 10.0 | 0.1 | |
| Other liabilities - notes in circulation | 2.1 | |||||
| 31 December 2018 | ||||||
| Financial assets | ||||||
| Cash and balances at central banks | 88.9 | |||||
| Settlement balances | 2.9 | |||||
| Loans to banks | 0.5 | 12.4 | 12.4 | - | 9.2 | 3.2 |
| Loans to customers | 305.1 | 301.7 | - | 0.5 | 301.2 | |
| Other financial assets | ||||||
| Securities | 11.8 | 11.8 | 7.3 | 3.0 | 1.5 | |
| Financial liabilities | ||||||
| Bank deposits | 4.2 | 19.1 | 18.5 | - | 13.9 | 4.6 |
| Customer deposits | 307.1 | 53.8 | 54.6 | - | 10.4 | 44.2 |
| Settlement balances | 3.1 | |||||
| Other financial liabilities | ||||||
| Debt securities in issue | 36.9 | 38.6 | - | 36.9 | 1.7 | |
| Subordinated liabilities | 9.7 | 10.0 | - | 9.9 | 0.1 | |
| Other liabilities - notes in circulation | 2.2 |
The fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Quoted market values are used where available; otherwise, fair values have been estimated based on discounted expected future cash flows and other valuation techniques. These techniques involve uncertainties and require assumptions and judgments covering prepayments, credit risk and discount rates. Furthermore, there is a wide range of potential valuation techniques. Changes in these assumptions would affect estimated fair values. The fair values reported would not necessarily be realised in an immediate sale or settlement.
| Payment protection |
Other customer |
Litigation and other regulatory |
|||
|---|---|---|---|---|---|
| insurance (1) | redress | (incl. RMBS) | Other (2) | Total | |
| £m £m |
£m | £m | £m | ||
| At 1 January 2019 | 695 | 536 | 783 | 990 | 3,004 |
| Implementation of IFRS 16 on 1 January 2019 (3) | - | - | - | (170) | (170) |
| ECL impairment release | - | - | - | (3) | (3) |
| Transfer to accruals and other liabilities | - | (4) | - | 1 | (3) |
| Currency translation and other movements | - | (7) | (6) | (16) | (29) |
| Charge to income statement | - | 17 | 5 | 33 | 55 |
| Releases to income statement | - | (12) | (9) | (16) | (37) |
| Provisions utilised | (136) | (81) | (6) | (114) | (337) |
| At 31 March 2019 | 559 | 449 | 767 | 705 | 2,480 |
| ECL impairment charge | - | - | - | 21 | 21 |
| Transfer from accruals and other liabilities | - | 4 | - | - | 4 |
| Currency translation and other movements | - | 3 | 3 | 4 | 10 |
| Charge to income statement | - | 64 | 18 | 100 | 182 |
| Releases to income statement | - | (11) | (33) | (70) | (114) |
| Provisions utilised | (116) | (90) | (28) | (79) | (313) |
| At 30 June 2019 | 443 | 419 | 727 | 681 | 2,270 |
Notes:
(1) 30 June 2019 includes provisions held in relation to offers made from 2018 and earlier years of £99 million.
(2) Materially comprises provisions relating to property closures and restructuring costs.
(3) Refer to Note 2 for further information on the impact of IFRS 16 implementation.
There are uncertainties as to the eventual cost of redress in relation to certain of the provisions contained in the table above. Assumptions relating to these are inherently uncertain and the ultimate financial impact may be different from the amount provided.
The Group's provision reflects the increased volume of complaints following the FCA's introduction of an August 2019 PPI timebar as outlined in FCA announcement CP17/3 and the introduction of new Plevin (unfair commission) complaint handling rules.
The principal assumptions underlying the Group's provision in respect of PPI sales are: assessment of the total number of complaints that the Group will receive; the proportion of these that will result in redress; and the average cost of such redress. The number of complaints has been estimated from an analysis of the Group's portfolio of PPI policies sold by vintage and by product. Estimates of the percentage of policyholders that will lodge complaints (the take up rate) and of the number of these that will be upheld (the uphold rate) have been established based on recent experience, guidance in FCA policy statements and the expected rate of responses from proactive customer contact. The average redress assumption is based on recent experience and FCA calculation rules. The table below shows the sensitivity of the provision to changes in the principal assumptions (all other assumptions remaining the same).
| Sensitivity | ||||
|---|---|---|---|---|
| Consequential change in | ||||
| Actual to | Future | Change in assumption | provision | |
| Assumptions | date | expected | % | £m |
| Customer initiated complaints (1) | 2,968k | 95k | +/- 5 | +/- 7 |
| Uphold rate (2) | 88% | 90% | +/- 1 | +/- 1 |
| Average redress (3) | £1,657 | £1,559 | +/- 5 | +/- 7 |
| Processing costs per claim (4) | £148 | £317 | +/- 20k claims | +/- 6 |
Notes:
(1) Claims received directly by RBS to date, including those received via CMCs and Plevin (commission) only. Excluding those for proactive mailings and where no PPI policy exists.
(2) Average uphold rate per customer initiated claims received directly by RBS including those received via CMCs, to end of timebar for both PPI (mis-sale) and Plevin (commission), excluding those for which no PPI policy exists.
(3) Average redress for PPI (mis-sale) and Plevin (commission) pay-outs.
(4) Processing costs per claim on a valid complaints basis, includes direct staff costs and associated overhead - excluding FOS fees.
On 5 February 2019 the Official Receiver appointed Deloitte to assist in the identification of potential claimants in respect of PPI. We are evaluating data suggesting 250,000 to 300,000 such claimants. The extent of the Group's share of any obligation in respect of ensuing claims cannot be ascertained with sufficient reliability for inclusion in the provision at 30 June 2019.
Background information for all material provisions is given in Note 13.
The 2018 final and special dividends recommended were approved by shareholders at the Annual General Meeting on 25 April 2019 and the payment made on 30 April 2019 to shareholders on the register at the close of business on 22 March 2019.
RBS announces an interim dividend for 2019 of £241 million, or 2p per ordinary share. In addition, the company announces a further special dividend of £1,449 million, or 12p per ordinary share.
The interim and special dividends will be paid on 20 September 2019 to shareholders on the register at close of business on 16 August 2019. The ex-dividend date will be 15 August 2019.
Loan exposure and impairment metrics
The table below summarises loans and related credit impairment measures on an IFRS 9 basis.
| 30 June | 31 December | |
|---|---|---|
| 2019 | 2018 | |
| £m | £m | |
| Loans - amortised cost | ||
| Stage 1 | 291,984 | 285,985 |
| Stage 2 | 25,705 | 26,097 |
| Stage 3 | 7,325 | 7,718 |
| 325,014 | 319,800 | |
| ECL provisions (1) | ||
| Stage 1 | 280 | 285 |
| Stage 2 | 682 | 763 |
| Stage 3 | 2,340 | 2,320 |
| 3,302 | 3,368 | |
| ECL provision coverage (2) | ||
| Stage 1 (%) | 0.10 | 0.10 |
| Stage 2 (%) | 2.65 | 2.92 |
| Stage 3 (%) | 31.95 | 30.06 |
| 1.02 | 1.05 | |
| Impairment losses | ||
| ECL charge (3) | 323 | 398 |
| Stage 1 | (140) | (143) |
| Stage 2 | 101 | 292 |
| Stage 3 | 362 | 249 |
| ECL loss rate - annualised (basis points) | 19.88 | 12.45 |
| Amounts written off | 452 | 1,494 |
Notes:
(1) Includes £4 million (31 December 2018 - £5 million) related to assets at FVOCI.
(2) ECL provisions coverage is ECL provisions divided by loans - amortised cost.
(3) Includes a £30 million charge (31 December 2018 - £3 million charge) related to other financial assets, of which nil (31 December 2018 - £1 million charge) related to assets at FVOCI and a £28 million charge (31 December 2018 - £31 million release) related to contingent liabilities.
| 30 June 2019 |
31 December 2018 |
|
|---|---|---|
| £m | £m | |
| Guarantees | 2,793 | 3,952 |
| Other contingent liabilities | 2,410 | 3,052 |
| Standby facilities, credit lines and other commitments | 120,862 | 119,879 |
| Contingent liabilities and commitments | 126,065 | 126,883 |
Contingent liabilities arise in the normal course of RBS's business; credit exposure is subject to the bank's normal controls. The amounts shown do not, and are not intended to, provide any indication of RBS's expectation of future losses.
The Royal Bank of Scotland Group plc (the 'company' or RBSG) and certain members of the Group are party to legal proceedings and the subject of investigation and other regulatory and governmental action ('Matters') in the United Kingdom (UK), the United States (US), the European Union (EU) and other jurisdictions.
RBS recognises a provision for a liability in relation to these Matters when it is probable that an outflow of economic benefits will be required to settle an obligation resulting from past events, and a reliable estimate can be made of the amount of the obligation.
In many proceedings and investigations, it is not possible to determine whether any loss is probable or to estimate reliably the amount of any loss, either as a direct consequence of the relevant proceedings and investigations or as a result of adverse impacts or restrictions on RBS's reputation, businesses and operations. Numerous legal and factual issues may need to be resolved, including through potentially lengthy discovery and document production exercises and determination of important factual matters, and by addressing novel or unsettled legal questions relevant to the proceedings in question, before a liability can reasonably be estimated for any claim. RBS cannot predict if, how, or when such claims will be resolved or what the eventual settlement, damages, fine, penalty or other relief, if any, may be, particularly for claims that are at an early stage in their development or where claimants seek substantial or indeterminate damages.
There are situations where RBS may pursue an approach that in some instances leads to a settlement agreement. This may occur in order to avoid the expense, management distraction or reputational implications of continuing to contest liability, or in order to take account of the risks inherent in defending claims or investigations, even for those Matters for which RBS believes it has credible defences and should prevail on the merits. The uncertainties inherent in all such Matters affect the amount and timing of any potential outflows for both Matters with respect to which provisions have been established and other contingent liabilities.
The future outflow of resources in respect of any Matter may ultimately prove to be substantially greater than or less than the aggregate provision that RBS has recognised. Where (and as far as) liability cannot be reasonably estimated, no provision has been recognised. RBS expects that in future periods, additional provisions, settlement amounts and customer redress payments will be necessary, in amounts that are expected to be substantial in some instances.
For a discussion of certain risks associated with the Group's litigation, investigations and reviews, see the Risk Factor relating to legal, regulatory and governmental actions and investigations set out in RBS's 2018 Annual Report and Accounts on page 261 and in RBS's 2018 Annual Report on Form 20-F on page 274.
RBS companies continue to defend RMBS-related claims in the US in which plaintiffs allege that certain disclosures made in connection with the relevant offerings of RMBS contained materially false or misleading statements and/or omissions regarding the underwriting standards pursuant to which the mortgage loans underlying the RMBS were issued. The remaining RMBS lawsuits against RBS companies consist of cases filed by the Federal Home Loan Banks of Boston and Seattle and the Federal Deposit Insurance Corporation that together involve the issuance of less than US\$1 billion of RMBS issued primarily from 2005 to 2007. In addition, NatWest Markets Securities Inc. previously agreed to settle a purported RMBS class action entitled New Jersey Carpenters Health Fund v. Novastar Mortgage Inc. et al. for US\$55.3 million, which was paid into escrow pending court approval of the settlement, which was granted on 11 March 2019, but which is now the subject of an appeal by a class member who does not want to participate in the settlement.
NatWest Markets Plc and certain other members of the Group, including RBSG, are defendants in a number of class actions and individual claims pending in the US (primarily in the United States District Court for the Southern District of New York (SDNY)) with respect to the setting of LIBOR and certain other benchmark interest rates. The complaints allege that certain members of the Group and other panel banks violated various federal laws, including the US commodities and antitrust laws, and state statutory and common law, as well as contracts, by manipulating LIBOR and prices of LIBOR-based derivatives in various markets through various means.
Several class actions relating to USD LIBOR, as well as more than two dozen non-class actions concerning USD LIBOR, are part of a co-ordinated proceeding in the SDNY. In December 2016, the SDNY held that it lacks personal jurisdiction over
NatWest Markets Plc with respect to certain claims. As a result of that decision, all Group companies have been dismissed from each of the USD LIBOR-related class actions (including class actions on behalf of over-the-counter plaintiffs, exchange-based purchaser plaintiffs, bondholder plaintiffs, and lender plaintiffs), but seven non-class cases in the co-ordinated proceeding remain pending against Group defendants. The dismissal of Group companies for lack of personal jurisdiction is the subject of a pending appeal to the United States Court of Appeals for the Second Circuit.
Among the non-class claims dismissed by the SDNY in December 2016 were claims that the Federal Deposit Insurance Corporation (FDIC) had asserted on behalf of certain failed US banks. In July 2017, the FDIC, on behalf of 39 failed US banks, commenced substantially similar claims against RBS companies and others in the High Court of Justice of England and Wales. The action alleges that the defendants breached English and European competition law as well as asserting common law claims of fraud under US law.
In addition, there are two class actions relating to JPY LIBOR and Euroyen TIBOR, both pending before the same judge in the SDNY. In the first class action, which relates to Euroyen TIBOR futures contracts, the court dismissed the plaintiffs' antitrust claims in March 2014, but declined to dismiss their claims under the Commodity Exchange Act for price manipulation, and the case is proceeding in the discovery phase. The second class action relates to other derivatives allegedly tied to JPY LIBOR and Euroyen TIBOR. The court dismissed that case in March 2017 on the ground that the plaintiffs lack standing. The plaintiffs have commenced an appeal of that decision.
There is also a class action relating to the Singapore Interbank Offered Rate and Singapore Swap Offer Rate pending in the SDNY. In that case, the court denied defendants' motion to dismiss on 5 October 2018 in a ruling that would have permitted certain antitrust claims to proceed against NatWest Markets Plc and other non-RBS defendants. However, on 26 July 2019, the court determined that the named plaintiffs asserting such claims do not have standing and therefore dismissed the case. The dismissal is subject to appeal.
Four other class action complaints were filed against RBS companies in the SDNY, each relating to a different reference rate. In the case relating to Pound Sterling LIBOR, the court dismissed all claims against RBS companies, for various reasons, on 21 December 2018, and plaintiffs are seeking reconsideration of that decision. In the case relating to the Australian Bank Bill Swap Reference Rate, the court dismissed all claims against RBS companies for lack of personal jurisdiction on 26 November 2018, but plaintiffs have filed an amended complaint, which is the subject of a further motion to dismiss. In the case relating to Euribor, the court dismissed all claims against RBS companies for lack of personal jurisdiction in February 2017, but in June 2019, the plaintiffs commenced an appeal of that decision. In the case relating to Swiss Franc LIBOR, the court dismissed all claims against all defendants on various grounds in September 2017, but held that it has personal jurisdiction over NatWest Markets Plc and allowed the plaintiffs to replead their complaint. Defendants' renewed motion to dismiss the amended complaint relating to Swiss Franc LIBOR remains pending.
NatWest Markets Plc has also been named as a defendant in a motion to certify a class action relating to LIBOR in the Tel Aviv District Court in Israel. NatWest Markets Plc has filed a motion for cancellation of service. If the motion is successful then the current action will be brought to an end, although the claimants may seek to re-raise the claim in the future.
NatWest Markets Plc is defending a claim in the High Court in London brought by London Bridge Holdings Ltd and others, in which the claimants allege LIBOR manipulation in connection with the sale of interest rate hedging products. The quantified sum claimed in that case is £446.7 million.
Details of UK litigation claims in relation to the alleged mis-sale of interest rate hedging products (IRHPs) involving LIBORrelated allegations are set out under 'Interest rate hedging products and similar litigation' on page 39.
In January 2019, a class action antitrust complaint was filed in the SDNY alleging that the defendants (USD ICE LIBOR panel banks and affiliates) have conspired to suppress USD ICE LIBOR from 2014 to the present by submitting incorrect information to ICE about their borrowing costs. The RBS defendants are RBSG, NatWest Markets Plc, NatWest Markets Securities Inc., and NatWest Plc.
NatWest Markets Plc, NatWest Markets Securities Inc. and / or RBSG, are defendants in several cases relating to NatWest Markets Plc's foreign exchange (FX) business, each of which is pending before the same federal judge in the SDNY.
In 2015, NatWest Markets Plc paid US\$255 million to settle the consolidated antitrust class action on behalf of persons who entered into over-the-counter FX transactions with defendants or who traded FX instruments on exchanges. That settlement received final court approval in August 2018. On 7 November 2018, some members of the settlement class who opted out of the settlement filed their own non-class complaint in the SDNY asserting antitrust claims against NatWest Markets Plc, NatWest Markets Securities Inc. and other banks. On 31 December 2018, some of the same claimants, as well as others, filed proceedings in the High Court in London, asserting competition claims against NatWest Markets Plc and several other banks. The claim was served on 25 April 2019.
Two other FX-related class actions remain pending in the SDNY. First, there is a class action on behalf of 'consumers and enduser businesses,' which is proceeding against NatWest Markets Plc in the discovery phase following the SDNY's denial of the defendants' motions to dismiss in March 2018. Second, there is a class action on behalf of 'indirect purchasers' of FX instruments (which plaintiffs define as persons who transacted FX instruments with retail foreign exchange dealers that transacted directly with defendant banks). That case is proceeding in discovery against NatWest Markets Securities Inc. and other defendants following the SDNY's denial of defendants' motion to dismiss on 25 October 2018. On 20 May 2019, NatWest Markets Plc was dismissed from the case for lack of personal jurisdiction, but plaintiffs are seeking permission to replead their complaint to establish jurisdiction.
On 27 May 2019, a class action was filed in the Federal Court of Australia against NatWest Markets Plc and other banks on behalf of persons who bought or sold currency through FX spots or forwards between 1 January 2008 and 15 October 2013 with a total transaction value exceeding AUS \$0.5m. RBSG has been named in the action as a 'cartel party', but is not a defendant. The claim was served on 28 June 2019.
On 29 July 2019, an application for a collective proceedings order was filed in the UK Competition Appeal Tribunal against RBSG, NatWest Markets Plc and other banks on behalf of persons who, between 18 December 2007 and 31 January 2013, entered into a relevant FX spot or outright forward transaction in the EEA with a relevant financial institution or on an electronic communications network.
Two motions to certify FX-related class actions have been filed in the Tel Aviv District Court in Israel. RBSG and NatWest Markets Securities Inc. have been named as defendants in the first motion. The Royal Bank of Scotland plc has been named in the second. These motions have not been served.
Certain other foreign exchange transaction related claims have been or may be threatened. RBS cannot predict whether any of these claims will be pursued, but expects that some may.
NatWest Markets Securities Inc. and certain other US broker-dealers are defendants in a consolidated antitrust class action pending in the SDNY on behalf of persons who transacted in US Treasury securities or derivatives based on such instruments, including futures and options. The plaintiffs allege that defendants rigged the US Treasury securities auction bidding process to deflate prices at which they bought such securities and colluded to increase the prices at which they sold such securities to plaintiffs. The defendants' motion to dismiss this matter remains pending.
Class action antitrust claims commenced in March 2019 are pending in the SDNY against NatWest Markets Plc, NatWest Markets Securities Inc. and other banks. The complaints allege a conspiracy among dealers of Euro-denominated bonds issued by European central banks (EGBs), to widen the bid-ask spreads they quoted to customers, thereby increasing the prices customers paid for the EGBs or decreasing the prices at which customers sold the bonds. The class consists of those who purchased or sold EGBs in the US between 2007 and 2012.
NatWest Markets Plc and other members of the Group, including RBSG, as well as a number of other interest rate swap dealers, are defendants in several cases pending in the SDNY alleging violations of the US antitrust laws in the market for interest rate swaps. There is a consolidated class action complaint on behalf of persons who entered into interest rate swaps with the defendants, as well as non-class action claims by three swap execution facilities (TeraExchange, Javelin, and trueEx). The plaintiffs allege that the swap execution facilities would have successfully established exchange-like trading of interest rate swaps if the defendants had not unlawfully conspired to prevent that from happening through boycotts and other means. Discovery in these cases is ongoing.
In addition, in June 2017, TeraExchange filed a complaint against RBS companies, including RBSG, as well as a number of other credit default swap dealers, in the SDNY. TeraExchange alleges it would have established exchange-like trading of credit default swaps if the defendant dealers had not engaged in an unlawful antitrust conspiracy. On 1 October 2018, the court dismissed all claims against RBS companies.
NatWest Markets N.V. (NWM N.V.) is a defendant in two actions filed by Irving Picard, as trustee for the bankruptcy estates of Bernard L. Madoff and Bernard L. Madoff Investment Securities LLC, in bankruptcy court in New York. In both cases, the trustee alleges that certain transfers received by NWM N.V. amounted to fraudulent conveyances that should be clawed back for the benefit of the Madoff estate.
In the primary action, filed in December 2010, the trustee originally sought to recover US\$75.8 million in redemptions that NWM N.V. allegedly received from certain Madoff feeder funds and US\$162.1 million that NWM N.V. allegedly received from certain swap counterparties. In August 2018, due to a court ruling in a related matter, the trustee voluntarily dismissed a portion of this claim (relating to US\$74.6 million received from certain swap counterparties) without prejudice to refiling at a later date. In June 2019, the trustee filed a motion for leave to file an amended complaint, seeking to clawback a total of US\$276.3 million, including the previously voluntarily dismissed US\$74.6 million, that NWM N.V. allegedly received in redemptions from certain Madoff feeder funds and swap counterparties. NWM N.V. intends to oppose the motion for leave to amend and otherwise seek dismissal of the amended complaint. In the second action, filed in October 2011, the trustee seeks to recover an additional US\$21.8 million. In November 2016, the bankruptcy court dismissed this case on international comity grounds, and that decision was appealed. On 25 February 2019, the United States Court of Appeals for the Second Circuit reversed the bankruptcy court's decision. If the U.S. Supreme Court declines to review the matter, the case will return to the bankruptcy court for further proceedings.
RBS is dealing with a number of active litigation claims in the UK in relation to the alleged mis-selling of interest rate hedging products (IRHPs). In general claimants allege that the relevant IRHPs were mis-sold to them, with some also alleging that misrepresentations were made in relation to LIBOR. Claims have been brought by customers who were considered under the UK Financial Conduct Authority (FCA) redress programme for IRHPs, as well as customers who were outside of the scope of that programme, which was closed to new entrants in March 2015. RBS remains exposed to potential claims from customers who were either ineligible to be considered for redress or who are dissatisfied with their redress offers.
Property Alliance Group (PAG) v NatWest Markets Plc was the leading case before the English High Court involving both IRHP mis-selling and LIBOR misconduct allegations. The amount claimed was £34.8 million. Following dismissal by the Court of all PAG's claims in December 2016, PAG appealed to the Court of Appeal, which dismissed the appeal in March 2018. In July 2018 the Supreme Court declined the request from PAG for permission to appeal an aspect of the judgment relating to implied representations of Sterling LIBOR rates. The Court of Appeal's decision may impact other IRHP and LIBOR-related cases currently pending in the English courts, some of which involve substantial amounts.
Separately, NatWest Markets Plc is defending claims filed in France by five French local authorities relating to structured interest rate swaps. The plaintiffs allege, among other things, that the swaps are void for being illegal transactions, that they were mis-sold, and that information / advisory duties were breached. Of the remaining claims, two are being appealed to the Supreme Court and one remains to be heard before the lower court.
HMRC issued a tax assessment in 2012 against RBSG for approximately £86 million regarding a value-added-tax ('VAT') matter in relation to the trading of European Union Allowances ('EUAs') by a joint venture subsidiary in 2009. RBSG has lodged an appeal, which is still to be heard, before the First-tier Tribunal (Tax), a specialist tax tribunal, challenging the assessment (the 'Tax Dispute'). In the event that the assessment is upheld, interest and costs would be payable, and a penalty of up to 100 per cent of the VAT held to have been legitimately denied by HMRC could also be levied. Separately, NatWest Markets Plc is a named defendant in civil proceedings before the High Court brought in 2015 by ten companies (all in liquidation) (the 'Liquidated Companies') and their respective liquidators (together, 'the Claimants'). The Liquidated Companies previously traded in EUAs in 2009 and are alleged to be defaulting traders within (or otherwise connected to) the EUA supply chains forming the subject of
the Tax Dispute. The Claimants claim approximately £71.4 million plus interest and costs and allege that NatWest Markets Plc dishonestly assisted the directors of the Liquidated Companies in the breach of their statutory duties and/or knowingly participated in the carrying on of the business of the Liquidated Companies with intent to defraud creditors. The trial in that matter concluded on 20 July 2018 and judgment is awaited.
NatWest Plc is defending lawsuits filed in the United States District Court for the Eastern District of New York by a number of US nationals (or their estates, survivors, or heirs) who were victims of terrorist attacks in Israel. The plaintiffs allege that NatWest Plc is liable for damages arising from those attacks pursuant to the US Anti-Terrorism Act because NatWest Plc previously maintained bank accounts and transferred funds for the Palestine Relief & Development Fund, an organisation which plaintiffs allege solicited funds for Hamas, the alleged perpetrator of the attacks.
In October 2017, the trial court dismissed claims against NatWest Plc with respect to two of the 18 terrorist attacks at issue. In March 2018, the trial court granted a request by NatWest Plc for leave to file a renewed summary judgment motion in respect of the remaining claims, and in March 2019, the court granted summary judgment in favour of NatWest Plc. The plaintiffs have commenced an appeal of the judgment to the United States Court of Appeals for the Second Circuit.
NWM N.V. and certain other financial institutions, are defendants in several actions pending in the United States District Courts for the Eastern and Southern Districts of New York, filed by a number of US nationals (or their estates, survivors, or heirs), most of whom are or were US military personnel, who were killed or injured in attacks in Iraq between 2003 and 2011. NatWest Markets Plc is also a defendant in some of these cases.
The attacks at issue in the cases were allegedly perpetrated by Hezbollah and certain Iraqi terror cells allegedly funded by the Islamic Republic of Iran. According to the plaintiffs' allegations, the defendants are liable for damages arising from the attacks because they allegedly conspired with Iran and certain Iranian banks to assist Iran in transferring money to Hezbollah and the Iraqi terror cells, in violation of the US Anti-Terrorism Act, by agreeing to engage in 'stripping' of transactions initiated by the Iranian banks so that the Iranian nexus to the transactions would not be detected. The first of these actions was filed in the United States District Court for the Eastern District of New York in November 2014. On 27 July 2018, the magistrate judge in that case issued a report to the district court recommending that the district court deny the defendants' pending motion to dismiss. NWM N.V. has requested that the district court grant the motion to dismiss notwithstanding the magistrate's recommendation. Another action, filed in 2017, was dismissed on 28 March 2019. The dismissal is subject to re-pleading by the plaintiffs or appeal. The other actions are either subject to a pending motion to dismiss, or will be the subject of such a motion in due course.
NatWest Markets Securities Inc. is an underwriter defendant in several securities class actions in the US in which plaintiffs generally allege that an issuer of public debt or equity securities, as well as the underwriters of the securities (including NatWest Markets Securities Inc.), are liable to purchasers for misrepresentations and omissions made in connection with the offering of such securities.
RBS's businesses and financial condition can be affected by the actions of various governmental and regulatory authorities in the UK, the US, the EU and elsewhere. RBS has engaged, and will continue to engage, in discussions with relevant governmental and regulatory authorities, including in the UK, the US, the EU and elsewhere, on an ongoing and regular basis, and in response to informal and formal inquiries or investigations, regarding operational, systems and control evaluations and issues including those related to compliance with applicable laws and regulations, including consumer protection, business conduct, competition/anti-trust, anti-bribery, anti-money laundering and sanctions regimes.
The NatWest Markets business in particular has been providing, and continues to provide, information regarding a variety of matters, including, for example, the setting of benchmark rates and related derivatives trading, conduct in the foreign exchange market, and various issues relating to the issuance, underwriting, and sales and trading of fixed-income securities, including structured products and government securities, some of which have resulted, and others of which may result, in investigations or proceedings.
Any matters discussed or identified during such discussions and inquiries may result in, among other things, further inquiry or investigation, other action being taken by governmental and regulatory authorities, increased costs being incurred by RBS, remediation of systems and controls, public or private censure, restriction of RBS's business activities and/or fines. Any of the events or circumstances mentioned in this paragraph or below could have a material adverse effect on RBS, its business, authorisations and licences, reputation, results of operations or the price of securities issued by it.
RBS is co-operating fully with the investigations and reviews described below.
In the US, RBS companies have in recent years been involved in investigations relating to, among other things, issuance, underwriting and trading in RMBS and other mortgage-backed securities and collateralised debt obligations (CDOs). Investigations by the US Department of Justice (DoJ) and several state attorneys general relating to the issuance and underwriting of RMBS were previously resolved. Certain other state attorneys general have sought information regarding similar issues, and RBS is aware that at least one such investigation is ongoing.
In October 2017, NatWest Markets Securities Inc. entered into a non-prosecution agreement (NPA) with the United States Attorney for the District of Connecticut (USAO) in connection with alleged misrepresentations to counterparties relating to secondary trading in various forms of asset-backed securities. In the NPA, the USAO agreed not to file criminal charges relating to certain conduct and information described in the NPA if NatWest Markets Securities Inc. complies with the NPA's reporting and conduct requirements during its term.
The NatWest Markets business is currently responding to a criminal investigation concerning unrelated securities trading by certain traders in 2018, which was reported to the USAO during the course of the NPA. In April 2019, NatWest Markets Securities Inc. agreed to a second six-month extension of the NPA so that the USAO could review the circumstances of that unrelated matter.
In May and June 2019, RBSG and NatWest Markets Plc reached settlements totalling approximately EUR 275 million in connection with the EC and certain other related competition law investigations into FX trading. The aggregate amount is fully covered by existing provisions in NatWest Markets Plc. NatWest Markets Plc continues to co-operate with ongoing investigations from competition authorities on similar issues relating to past FX trading. The exact timing and amount of future financial penalties, related risks and collateral consequences remain uncertain and may be material.
In 2014 and 2015, NatWest Markets Plc paid significant penalties to resolve investigations into its FX business by the FCA, the CFTC, the DoJ, and the Board of Governors of the Federal Reserve System (Federal Reserve). As part of its plea agreement with the DoJ, NatWest Markets Plc pled guilty to a one-count information charging an antitrust conspiracy occurring between as early as December 2007 to at least April 2010. NatWest Markets Plc admitted that it knowingly, through one of its Euro/US dollar currency traders, joined and participated in a conspiracy to eliminate competition in the purchase and sale of the Euro/US dollar currency pair exchanged in the FX spot market. On 5 January 2017, the United States District Court for the District of Connecticut imposed a sentence on NatWest Markets Plc consisting of a US\$395 million fine and a three-year probation, which among other things, prohibits NatWest Markets Plc from committing another crime in violation of US law or engaging in the FX trading practices that form the basis for the charged crime and requires NatWest Markets Plc to implement a compliance program designed to prevent and detect the unlawful conduct at issue and to strengthen its compliance and internal controls as required by other regulators (including the FCA and the CFTC). A violation of the terms of probation could lead to the imposition of additional penalties.
As part of the settlement with the Federal Reserve, NatWest Markets Plc and NatWest Markets Securities Inc. entered into a cease and desist order (the FX Order). In the FX Order, which is publicly available and will remain in effect until terminated by the Federal Reserve, NatWest Markets Plc and NatWest Markets Securities Inc. agreed to take certain remedial actions with respect to FX activities and certain other designated market activities, including the creation of an enhanced written internal controls and compliance program, an improved compliance risk management program, and an enhanced internal audit program. NatWest Markets Plc and NatWest Markets Securities Inc. are obligated to implement and comply with these programs as approved by the Federal Reserve, and are also required to conduct, on an annual basis, a review of applicable compliance policies and procedures and a risk-focused sampling of key controls.
In 2014, the FCA appointed an independent Skilled Person under section 166 of the Financial Services and Markets Act 2000 to review RBS's treatment of SME customers whose relationship was managed by RBS's Global Restructuring Group (GRG) in the period 1 January 2008 to 31 December 2013.
The Skilled Person delivered its final report to the FCA during September 2016, and the FCA published an update in November 2016. In response, RBS announced redress steps for SME customers in the UK and the Republic of Ireland that were in GRG between 2008 and 2013. These steps were (i) an automatic refund of certain complex fees; and (ii) a new complaints process, overseen by an independent third party. The complaints process closed on 22 October 2018 for new complaints in the UK and 31 December 2018 in the Republic of Ireland, with the exception of a small cohort of potential complainants in the Republic of Ireland for whom there is an extended deadline until 31 August 2019.
RBS provisions to date totalled £481 million in respect of the above redress steps, of which £328 million had been utilised by 30 June 2019.
The FCA published a summary of the Skilled Person's report in November 2017. The UK House of Commons Treasury Select Committee, seeking to rely on Parliamentary powers, published the full version of the Skilled Person's report in February 2018. In July 2018, the FCA confirmed that it had concluded its investigation and that it did not intend to take disciplinary or prohibitory action against any person in relation to these matters. On 13 June 2019, the FCA published a full report explaining how it had reached that conclusion.
As a result of an FSA review in 2013, the FCA required RBS to carry out a past business review and customer contact exercise on a sample of historic customers who received investment advice on certain lump sum products, during the period from March 2012 until December 2012. The review was conducted by an independent Skilled Person under section 166 of the Financial Services and Markets Act 2000. Redress was paid to certain customers in that sample group.
RBS later agreed with the FCA that it would carry out a wider review/remediation exercise relating to certain investment, insurance and pension sales from 1 January 2011 to 1 April 2015. That exercise is now complete. Phase 2 (covering sales in 2010) started in April 2018 and, with the exception of a small cohort of former customers for whom there is an extended completion date, is targeted for material completion by the end of September 2019.
In addition, RBS agreed with the FCA that it would carry out a remediation exercise, for a specific customer segment who were sold a particular structured product. Redress was paid to certain customers who took out the structured product.
RBS provisions in relation to these matters at 30 June 2019 were less than £10 million.
RBS has had dedicated resources in place since 2013 to investigate and resolve packaged account complaints on an individual basis. RBS provisions for this matter to date totalled £444 million, of which £411 million had been utilised by 30 June 2019. The FCA conducted a thematic review of packaged bank accounts across the UK from October 2014 to April 2016, the results of which were published in October 2016. RBS made amendments to its sales process and complaints procedures to address the findings from that review.
In July 2017, the FCA notified RBS that it was undertaking an investigation into RBS's compliance with the Money Laundering Regulations 2007 in relation to certain customers. There are currently two areas under review: (1) compliance with Money Laundering Regulations in respect of Money Service Business customers; and (2) the Suspicious Transactions regime in relation to the events surrounding particular customers. The investigations in both areas are assessing both criminal and civil culpability. RBS is cooperating with the investigations, including responding to several information requests from the FCA.
In December 2018, the FCA commenced a Systematic Anti-Money Laundering Programme assessment of RBS. The FCA provided its written findings to RBS on 28 June 2019, and RBS is considering these. It is not yet possible to assess the likely impact of this matter.
Since 2011, RBS has been implementing the FCA's policy statement for the handling of complaints about the mis-selling of PPI (Policy Statement 10/12). In August 2017, the FCA's new rules and guidance on PPI complaints handling (Policy Statement 17/3) came into force. The Policy Statement introduced new so called 'Plevin' rules, under which customers may be eligible for redress if the bank earned a high level of commission from the sale of PPI, but did not disclose this detail at the point of sale. The Policy Statement also introduced a two year PPI deadline, due to expire on 29 August 2019, before which new PPI complaints must be made. RBS is implementing the Policy Statement.
RBS has made provisions totalling £5.3 billion to date for PPI claims of which £4.9 billion had been utilised by 30 June 2019.
In December 2016, the FCA launched a market study into the provision of mortgages. On 26 March 2019 the final report was published. This found that competition was working well for many customers but also proposed remedies to help customers shop around more easily for mortgages. A period of consultation is underway and the FCA has indicated that it intends to provide updates on the remedies in due course.
In May 2017 the FCA announced a strategic review of retail banking models. The FCA used the review to understand how these models operate, including how 'free if in credit' banking is paid for and the impact of changes such as increased use of digital channels and reduced branch usage.
On 18 December 2018, the FCA published its final report containing a number of findings, including that personal current accounts are an important source of competitive advantage for major banks. Following the review, the FCA is to continue to monitor retail banking models, analyse new payments business models and undertake exploratory work to understand certain aspects of SME banking.
In December 2015, Coutts & Co Ltd., a member of the Group incorporated in Switzerland, entered into a non-prosecution agreement (the NPA) with the DoJ. This was entered into as part of the DoJ's programme for Swiss banks, related to its investigations of the role that Swiss banks played in concealing the assets of US tax payers in offshore accounts (US related accounts). Coutts & Co Ltd. paid a US\$78.5 million penalty and acknowledged responsibility for certain conduct set forth in a statement of facts accompanying the agreement. Under the NPA, which has a term of four years, Coutts & Co Ltd. is required, among other things, to provide certain information, cooperate with the DoJ's investigations, and commit no US federal offences. If Coutts & Co Ltd. abides by the NPA, the DoJ will not prosecute it for certain tax-related and monetary transaction offences in connection with US related accounts.
Since the signing of the NPA in 2015, Coutts & Co Ltd identified and disclosed to the DoJ a number of US related accounts that were not included in its original submission supporting the NPA. As a result of this, Coutts & Co Ltd agreed with the DoJ to undertake additional review work, which began in October 2018 and is now largely complete. This additional review work identified further US related accounts, which are being discussed with the DoJ.
In February 2017, the Swiss Financial Market Supervisory Authority (FINMA) took enforcement action against Coutts & Co Ltd with regard to failures of money laundering checks and controls on certain client accounts that were connected with the Malaysian sovereign wealth fund, 1MDB, and were held with Coutts & Co Ltd. FINMA accordingly required Coutts & Co Ltd to disgorge profits of CHF 6.5 million. There are two administrative criminal proceedings pending before the Swiss Finance Department against two former employees of Coutts & Co Ltd. In addition, the Monetary Authority of Singapore (MAS)'s supervisory examination of Coutts & Co Ltd's Singapore branch revealed breaches of anti-money laundering requirements. MAS imposed on Coutts & Co Ltd financial penalties amounting to SGD 2.4 million in December 2016.
In addition, Coutts & Co Ltd continues to assist with investigations and enquiries from authorities where requested to do so.
Media coverage in March 2019 highlighted an alleged money laundering scheme involving Russian and Lithuanian entities between 2006 and 2013. The media reports alleged that certain European banks, including ABN AMRO and Coutts, and at least one US bank, were involved in processing certain transactions associated with this scheme. RBS has responded to regulatory requests for information.
In December 2015, the Central Bank of Ireland (CBI) announced that it had written to a number of lenders requiring them to put in place a robust plan and framework to review the treatment of customers who had been sold mortgages with a tracker interest rate or with a tracker interest rate entitlement. The CBI stated that the intended purpose of the review was to identify any cases where customers' contractual rights under the terms of their mortgage agreements were not fully honoured, or where lenders did not fully comply with various regulatory requirements and standards regarding disclosure and transparency for customers. The CBI required Ulster Bank Ireland DAC (UBI DAC), a member of the Group incorporated in the Republic of Ireland, to participate in this review. UBI DAC submitted its phase 2 report to the CBI in March 2017, identifying impacted customers. The redress and compensation phase (phase 3) has now concluded although an appeals process is currently anticipated to run until approximately Q3 2020.
RBS has made provisions totalling €312 million (£279 million) to date for this matter, of which €252million (£226 million) had been utilised by 30 June 2019.
Separately, in April 2016, the CBI notified UBI DAC that it was also commencing an investigation under its Administrative Sanctions Procedure into suspected breaches of the Consumer Protection Code 2006 during the period 4 August 2006 to 30 June 2008 in relation to certain customers who switched from tracker mortgages to fixed rate mortgages. This investigation remains ongoing and UBI DAC continues to co-operate with the CBI.
As part of an internal review of the wider retail and commercial loan portfolios extending from the tracker mortgage examination programme, UBI DAC identified further legacy business issues. A programme remains ongoing to identify and remediate impacted customers. RBS has made provisions totalling €167 million (£150 million), of which €66 million (£59 million) had been utilised by 30 June 2019.
The UK Government and bodies controlled or jointly controlled by the UK Government and bodies over which it has significant influence are related parties of the Group. The Group enters into transactions with many of these bodies on an arm's length basis.
In the ordinary course of business, the Group may from time to time access market-wide facilities provided by the Bank of England. The Group's other transactions with the UK Government include the payment of taxes, principally UK corporation tax and value added tax; national insurance contributions; local authority rates; and regulatory fees and levies (including the bank levy and FSCS levies).
(a) In their roles as providers of finance, Group companies provide development and other types of capital support to businesses. These investments are made in the normal course of business and on arm's length terms. In some instances, the investment may extend to ownership or control over 20% or more of the voting rights of the investee company. However, these investments are not considered to give rise to transactions of a materiality requiring disclosure under IAS 24.
(b) The Group recharges The Royal Bank of Scotland Group Pension Fund with the cost of administration services incurred by it. The amounts involved are not material to the Group.
Full details of the Group's related party transactions for the year ended 31 December 2018 are included in the 2018 Annual Report and Accounts.
Other than as disclosed in this document there have been no significant events between 30 June 2019 and the date of approval of this announcement which would require a change to, or additional disclosure, in the announcement.
This announcement was approved by the Board of Directors on 1 August 2019.
We have been engaged by The Royal Bank of Scotland Group plc ("the Company" or "the Group") to review the condensed consolidated financial statements in the half-yearly financial report for the six months ended 30 June 2019 which comprise the condensed consolidated income statement, the condensed consolidated statement of comprehensive income, the condensed consolidated balance sheet, the condensed consolidated statement of changes in equity, the condensed consolidated cash flow statement, related Notes 1 to 16, and the Capital and risk management disclosures set out in Appendix 1 for those identified as within the scope of our review (together "the condensed consolidated financial statements"). We have read the other information contained in the half-yearly financial report and considered whether it contains any apparent misstatements or material inconsistencies with the information in the condensed consolidated financial statements.
This report is made solely to the Company in accordance with International Standard on Review Engagements (UK and Ireland) 2410 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity' issued by the Auditing Practices Board. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company, for our work, for this report, or for the conclusions we have formed.
The half-yearly financial report is the responsibility of, and has been approved by, the directors. The directors are responsible for preparing the half-yearly financial report in accordance with the Disclosure Guidance and Transparency Rules of the United Kingdom's Financial Conduct Authority.
As disclosed in Note 1, the annual financial statements of the Group are prepared in accordance with IFRSs as adopted by the European Union. The condensed consolidated financial statements included in this half-yearly financial report have been prepared in accordance with International Accounting Standard 34, 'Interim Financial Reporting', as adopted by the European Union.
Our responsibility is to express to the Company a conclusion on the condensed consolidated financial statements in the halfyearly financial report based on our review.
We conducted our review in accordance with International Standard on Review Engagements (UK and Ireland) 2410 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity' issued by the Auditing Practices Board for use in the United Kingdom. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK) and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.
Based on our review, nothing has come to our attention that causes us to believe that the condensed consolidated financial statements in the half-yearly financial report for the six months ended 30 June 2019 are not prepared, in all material respects, in accordance with International Accounting Standard 34 as adopted by the European Union and the Disclosure and Transparency Rules of the United Kingdom's Financial Conduct Authority.
Ernst & Young LLP Statutory Auditor London, United Kingdom 1 August 2019
Set out below is a summary of certain risks which could adversely affect the Group; it should be read in conjunction with the Capital and risk management section of the Group's 2018 Annual Report and Accounts and Form 20-F. This summary should not be regarded as a complete and comprehensive statement of all potential risks and uncertainties or of the Group's 2018 Annual Report and Accounts or Form 20-F risk factor disclosures. A fuller description of these and other risk factors is included on pages 253 to 263 of the 2018 Annual Report and Accounts and on pages 265 to 275 of the Group's Form 20-F which should be read together with the Group's other public disclosures.
We, the directors listed below, confirm that to the best of our knowledge:
By order of the Board
Howard Davies Ross McEwan Katie Murray
Chairman Chief Executive Chief Financial Officer
1 August 2019
Board of directors
Howard Davies Ross McEwan
Katie Murray
Frank Dangeard Alison Davis Patrick Flynn Morten Friis Robert Gillespie Brendan Nelson Baroness Noakes Mike Rogers Mark Seligman Dr Lena Wilson
In this document, 'RBSG plc' or the 'parent company' refers to The Royal Bank of Scotland Group plc, and 'RBS' or the 'Group' refers to RBSG plc and its subsidiaries.
Financial information contained in this document does not constitute statutory accounts within the meaning of section 434 of the Companies Act 2006 ('the Act'). The statutory accounts for the year ended 31 December 2018 have been filed with the Registrar of Companies. The report of the auditor on those statutory accounts was unqualified, did not draw attention to any matters by way of emphasis and did not contain a statement under section 498(2) or (3) of the Act.
The unaudited condensed consolidated financial statements for the half year ended 30 June 2019 comprise the following sections of this document:
The above sections are within the scope of the independent review performed by Ernst & Young LLP (EY). Refer to the Independent review report to The Royal Bank of Scotland Group plc on page 45 for further information.
This document contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, such as statements that include, without limitation, the words 'expect', 'estimate', 'project', 'anticipate', 'commit', 'believe', 'should', 'intend', 'plan', 'could', 'probability', 'risk', 'Value-at-Risk (VaR)', 'target', 'goal', 'objective', 'may', 'endeavour', 'outlook', 'optimistic', 'prospects' and similar expressions or variations on these expressions. These statements concern or may affect future matters, such as RBSG's future economic results, business plans and current strategies. In particular, this document may include forward-looking statements relating to RBSG in respect of, but not limited to: its regulatory capital position and related requirements, its financial position, profitability and financial performance (including financial, capital and operational targets), its access to adequate sources of liquidity and funding, increasing competition from new incumbents and disruptive technologies, its exposure to third party risks, its ongoing compliance with the UK ring-fencing regime and ensuring operational continuity in resolution, its impairment losses and credit exposures under certain specified scenarios, substantial regulation and oversight, ongoing legal, regulatory and governmental actions and investigations, LIBOR, EURIBOR and other benchmark reform and RBSG's exposure to economic and political risks (including with respect to Brexit and climate change), operational risk, conduct risk, cyber and IT risk, key person risk and credit rating risk. Forward-looking statements are subject to a number of risks and uncertainties that might cause actual results and performance to differ materially from any expected future results or performance expressed or implied by the forward-looking statements. Factors that could cause or contribute to differences in current expectations include, but are not limited to, legislative, political, fiscal and regulatory developments, accounting standards, competitive conditions, technological developments, interest and exchange rate fluctuations and general economic conditions. These and other factors, risks and uncertainties that may impact any forward-looking statement or RBSG's actual results are discussed in RBSG's UK 2018 Annual Report and Accounts (ARA), RBSG's Interim Results for H1 2019 (contained herein) and materials filed with, or furnished to, the US Securities and Exchange Commission, including, but not limited to, RBSG's most recent Annual Report on Form 20-F and Reports on Form 6-K. The forward-looking statements contained in this document speak only as of the date of this document and RBSG does not assume or undertake any obligation or responsibility to update any of the forward-looking statements contained in this document, whether as a result of new information, future events or otherwise, except to the extent legally required.
| 30 June | 31 March | 31 December | |
|---|---|---|---|
| 2019 | 2019 | 2018 | |
| Ordinary share price | 222.0p | 247.0p | 216.7p |
| Number of ordinary shares in issue (millions) | 12,091 | 12,090 | 12,049 |
Financial calendar
| 2019 third quarter interim management statement | 24 October 2019 |
|---|---|
| Analyst enquiries: | Alexander Holcroft Investor Relations +44 (0) 207 672 1982 |
Media enquiries: RBS Press Office +44 (0) 131 523 4205 |
|
|---|---|---|---|
| Analyst and investor presentation | Fixed income call | Web cast and dial in details | |
| Date: | Friday 2 August 2019 | Friday 2 August 2019 | www.rbs.com/results |
| Time: | 9:30 am UK time | 1:00 pm UK time | International – +44 (0) 20 3057 6566 |
| Conference ID: 4519918 | 7788826 | UK Free Call – 0800 279 6637 | |
| US Local Dial-In, New York - 1 646 517 | |||
| 5063 |
● Interim Results 2019 and background slides.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.